Non-fluorescent compound and uses thereof

A non-fluorescent compound capable of static and dynamic quenching across a wide wavelength range addresses the limitations of conventional quenchers, enabling effective quenching of various fluorescent compounds and improving nucleic acid detection methods.

WO2024228496A1PCT designated stage expired Publication Date: 2024-11-07SFC CO LTD
View PDF 27 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2024/005155
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-04-12
Filing Date
2024-04-17
Publication Date
2024-11-07

AI Technical Summary

Technical Problem

Conventional quenchers for fluorescent compounds often exhibit limited wavelength range effectiveness due to specific mechanisms like FRET, restricting the types of fluorescent compounds that can be used together, while ground state quenching requires wavelength overlap, limiting versatility.

Method used

A non-fluorescent compound capable of both static and dynamic quenching, represented by a specific formula, which can form complexes with various fluorescent compounds across a wide wavelength range, including 200 to 1000 nm, through mechanisms like FRET and ground state complex formation.

Benefits of technology

Enables effective quenching across a broad wavelength range, allowing for the use of diverse fluorescent compounds with a single quencher, enhancing the versatility of fluorescent assays and nucleic acid detection methods.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2024005155_07112024_PF_FP_ABST
    Figure KR2024005155_07112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to: a non-fluorescent compound useful as a quencher for a fluorescent compound exhibiting luminescence properties at an excited energy level; and various uses thereof.
Need to check novelty before this filing date? Find Prior Art

Description

Non-fluorescent compounds and their uses

[0001] The present invention relates to non-fluorescent compounds useful as quenchers for fluorescent compounds exhibiting luminescence properties at excited energy levels and to various uses thereof.

[0002] A quencher is a non-fluorescent compound that can quench the luminescence characteristic of a specific wavelength range exhibited by a fluorescent compound.

[0003] The fluorescence quenching phenomenon by the non-fluorescent compound and / or the chemical moiety contained in the non-fluorescent compound can be expressed by various mechanisms such as static quenching or dynamic quenching.

[0004] A representative example of static quenching is ground state quenching, and representative examples of dynamic quenching include fluorescence resonance energy transfer (FRET) and photo-induced electron transfer.

[0005] Among the mechanisms of the aforementioned quenching phenomenon, the most common FRET can occur when the emission spectrum of a fluorescent compound overlaps with the absorption spectrum of a quencher, and the fluorescent compound and the quencher exist within a distance (so-called Förster distance) sufficient to exhibit quenching. In other words, since quenching by FRET occurs within the wavelength overlap region of the emission spectrum of a fluorescent compound and the absorption spectrum of the quencher, it is difficult for a single quencher designed to induce FRET-induced quenching to exhibit uniform quenching characteristics within a wide wavelength range. Therefore, a single quencher designed to induce FRET-induced quenching generally exhibits quenching characteristics limited to a narrow wavelength range, or exhibits quenching characteristics in a region of the emission spectrum of a fluorescent compound where it is relatively easy to exhibit quenching characteristics.

[0006] For example, BHQ-1, a commercially available quencher, can absorb light in the wavelength range of 500 to 550 nm, and thus can quench the luminescence of fluorescein, which emits light at a wavelength of approximately 520 nm. In addition, BHQ-3 can absorb light in the wavelength range of 650 to 700 nm, and thus has difficulty quenching the luminescence of fluorescein, but can quench the luminescence of cy5, which emits light at a wavelength of approximately 670 nm.

[0007] Thus, because the wavelength range over which a single quencher can exhibit effective quenching properties is narrow, the types of fluorescent compounds that can be used in combination with a single quencher are inevitably limited.

[0008] Meanwhile, among the mechanisms of quenching, ground state quenching, unlike FRET, can occur without wavelength overlap between the emission spectrum of the fluorescent compound and the absorption spectrum of the quencher. Ground state quenching is generally referred to as contact quenching because it occurs when the fluorescent compound and the quencher exist within a sufficient distance from each other to form a ground state complex. The ground state complex can be formed when the fluorescent compound and the quencher exist within a sufficiently close distance within a dual-labeled oligonucleotide, each end of which is labeled with a fluorescent compound and a quencher, before hybridizing with the target nucleic acid sequence.

[0009] Since this ground state quenching does not require wavelength overlap between the emission spectrum of the fluorescent compound and the absorption spectrum of the quencher, if a single quencher can form a ground state by forming a complex with multiple fluorescent compounds having different emission wavelengths, the single quencher can exhibit quenching properties within a broad wavelength range even outside the emission spectrum region of the fluorescent compound.

[0010] Accordingly, if both static quenching and dynamic quenching are possible through a single non-fluorescent compound, it is expected that it will be possible to exhibit quenching phenomena in various fluorescent compounds or within a wide wavelength range.

[0011] As described above, the present invention aims to provide a non-fluorescent compound that can be used as a quencher in a wide wavelength range or for various fluorescent compounds by enabling both static quenching and dynamic quenching by a single non-fluorescent compound.

[0012] In addition, the present invention aims to provide a conjugate using the above non-fluorescent compound as a quencher, particularly a conjugate for labeling nucleic acids.

[0013] In addition, the present invention aims to provide a composition for detecting nucleic acids using a conjugate using the above non-fluorescent compound as a quencher, a support for detecting nucleic acids, and a method for detecting nucleic acids.

[0014] According to one aspect of the present invention, a non-fluorescent compound represented by the following chemical formula 1 is provided, wherein the non-fluorescent compound is capable of reducing fluorescence in a wide wavelength range of various fluorescent compounds by at least one mechanism selected from static quenching and dynamic quenching.

[0015] [Chemical Formula 1]

[0016]

[0017] Here,

[0018] Ar is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 It is an aliphatic-aromatic mixed ring,

[0019] wherein the above Ar is optionally substituted with at least one R",

[0020] R1 to R6, R' and R" are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from,

[0021] R x is a reactive group or a group having at least one reactive group bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms,

[0022] The above reactive groups are carboxyl, carboxyl derivatives, carboxylate (-CO2 -), carboxylates, hydroxyls, dienes, aldehydes, substituted ketones, sulfonyl halides, thiols, unsubstituted amino, primary amino, alkenes, alkynes, halogens, hydrazides, azides, imides, ketenes, isocyanates, thiocyanates, isothiocyanates, epoxides, maleimides, 1,2,4,5-tetrazine derivatives, cycloalkyne derivatives, cycloalkenes, triphosphates and phosphoramidites, substituted thioketones, haloformyl, formyl, acyl, acylamide, acyl azides, organic acid anhydrides, anilines, aziridines, boronates, carbodiimides, diazoalkynes, haloacetamides, imido esters, glycols, halotriazines, hydrazines, acyl halides, alkyl halides and aryl halides. is the functional group of choice,

[0023] R s is a carrier molecule or a group having at least one carrier molecule bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms,

[0024] R7 and R8 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from,

[0025] X is CR 20 R21 , NR 22 , O, S, and

[0026] R 20 Inland R 22 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x and R s are selected from, or combined with each other to form an optionally substituted 5- to 7-membered ring,

[0027] n is an integer from 0 to 5,

[0028] Two adjacent groups among R1 to R6 may combine with each other to form an optionally substituted 5- to 7-membered ring,

[0029] The non-fluorescent compound represented by the above chemical formula 1 has at least one R X or R S exists.

[0030] According to another aspect of the present invention, a conjugate comprising a non-fluorescent compound as defined herein as a quencher is provided.

[0031] According to another aspect of the present invention, a composition for detecting a nucleic acid comprising a conjugate as defined herein is provided.

[0032] According to another aspect of the present invention, a support for detecting nucleic acids is provided, comprising a non-fluorescent compound as defined herein as a quencher.

[0033] According to another aspect of the present invention, a method for detecting a nucleic acid using a conjugate comprising a non-fluorescent compound as defined herein as a quencher is provided.

[0034] The non-fluorescent compounds defined herein are capable of both static and dynamic quenching, enabling them to exhibit quenching for a variety of fluorescent compounds. Furthermore, unlike conventional quenchers that operate via dynamic quenching, the non-fluorescent compounds defined herein are capable of exhibiting quenching via static quenching, enabling them to exhibit quenching within a broader wavelength range.

[0035] Accordingly, the non-fluorescent compound defined herein has an advantage in that it can be used in combination with a wider variety of fluorescent compounds together with a single quencher because the wavelength range over which it can exhibit effective quenching properties even with just a single substance is wide.

[0036] Figure 1 is a schematic diagram of a hybrid of a forward probe and a reverse probe manufactured in Experimental Example 2.

[0037] Figures 2 and 3 show the results of a PCR experiment using a double-labeled oligonucleotide according to Experimental Example 4.

[0038] Figures 4 to 6 show the results of a PCR experiment using a double-labeled oligonucleotide according to Experimental Example 5.

[0039] Figures 7 and 8 show the results of a PCR experiment using a double-labeled oligonucleotide according to Experimental Example 6.

[0040] Figures 9 to 12 show the results of a PCR experiment using a double-labeled oligonucleotide according to Experimental Example 7.

[0041] Figure 13 shows the results of a PCR experiment using triple-labeled oligonucleotides according to Experimental Example 8.

[0042]

[0043] To facilitate understanding of the present invention, certain terms are defined herein for convenience. Unless otherwise defined herein, scientific and technical terms used herein may have the meanings commonly understood by those of ordinary skill in the relevant technical field.

[0044] Additionally, unless the context specifically states otherwise, a singular term includes its plural form, and a plural term may also include its singular form.

[0045]

[0046] non-fluorescent compounds

[0047] According to one aspect of the present invention, a non-fluorescent compound capable of reducing fluorescence by at least one mechanism selected from static quenching and dynamic quenching is provided.

[0048] The quenching wavelength range of the above non-fluorescent compound may vary depending on the emission spectrum of its counterpart fluorescent compound, but it can exhibit quenching properties in the wavelength range of 200 to 1000 nm.

[0049] Additionally, the non-fluorescent compounds defined herein can quench the luminescence properties of fluorescent compounds by both static quenching and dynamic quenching.

[0050] For example, the non-fluorescent compound can reduce the fluorescence of a fluorescent compound having an absorption or emission spectrum of 300 nm to 900 nm, preferably 550 nm to 900 nm, and more preferably 550 nm to 800 nm, by dynamic quenching. Specifically, the dynamic quenching may be by a FRET mechanism. In addition, the non-fluorescent compound can reduce the fluorescence of a fluorescent compound having an absorption or emission spectrum of 200 nm to 1000 nm, preferably 300 nm to 900 nm, by static quenching. Specifically, the static quenching may be induced by the non-fluorescent compound forming a ground state complex with the fluorescent compound.

[0051] Therefore, the non-fluorescent compounds defined herein can reduce fluorescence in a wide wavelength range (e.g., 200-1000 nm) by two quenching mechanisms (dynamic quenching and static quenching), and thus have the advantage of being usable as counterparts to various fluorescent compounds rather than quenchers that reduce fluorescence by only a single quenching mechanism.

[0052] The above non-fluorescent compound is represented by the following chemical formula 1. In addition, the above chemical formula 1 may exist as a resonance structure represented by the following chemical formula 1-1.

[0053] [Chemical Formula 1]

[0054]

[0055] [Chemical Formula 1-1]

[0056]

[0057] Here, Ar is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 It is an aliphatic-aromatic mixed ring, and n is an integer from 0 to 5.

[0058] As used herein, aryl means an unsaturated aromatic ring comprising a single ring or multiple rings (preferably 1 to 6 rings) connected to each other by fusion or covalent bonds (e.g., single bonds), and heteroaryl means an unsaturated aromatic ring in which at least one carbon atom in the aryl is replaced by a heteroatom (e.g., nitrogen, oxygen, or sulfur).

[0059] Non-limiting examples of aryls include phenyl, biphenyl, terphenyl, naphthyl, anthryl, phenanthrenyl, pyrenyl, fluoranthenyl, and their fused analogs.

[0060] Non-limiting examples of heteroaryl include furyl, tetrahydrofuryl, phrrolyl, pyrrolidinyl, thienyl, tetrahydrothienyl, oxazolyl, isoxazolyl, triazolyl, thiazolyl, isothiazolyl, pyrazolyl, pyrazolidinyl, oxadiazolyl, thiadiazolyl, imidazolyl, imidazolinyl, pyridyl, pyridaziyl, triazinyl, piperidinyl, morpholinyl, There are thiomorpholinyl, pyrazinyl, piperainyl, pyrimidinyl, naphthyridinyl, benzofuranyl, benzothienyl, indolyl, indolinyl, indolizinyl, indazolyl, quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, pteridinyl, quinuclidinyl, carbazoyl, acridinyl, phenazinyl, phenothizinyl, phenoxazinyl, purinyl, benzimidazolyl, and benzothiazolyl, and their conjugated analogues.

[0061] As used herein, the term "aliphatic-aromatic mixed ring" refers to a multiple ring (preferably 2 to 6 rings) in which an aliphatic ring and an aromatic ring are connected to each other by a fusion or covalent bond (e.g., a single bond). In addition, as used herein, the term "aliphatic ring" refers to a saturated hydrocarbon ring (cycloalkyl) or a saturated hydrocarbon ring (heterocycloalkyl) in which at least one carbon atom in the hydrocarbon ring is substituted with a heteroatom, and each corresponds to a cyclic structure of alkyl or heteroalkyl.

[0062] Non-limiting examples of aliphatic rings include cyclopentyl, cyclohexyl, cyclohexenyl, cycloheptyl, 1-(1,2,5,6-tetrahydropyridyl), 1-piperidinyl, 2-piperidinyl, 3-piperidinyl, 4-morpholinyl, 3-morpholinyl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-piperazinyl, 2-piperazinyl, and the like.

[0063] For example, the above Ar can be selected from [Ar-1] to [Ar-6] below.

[0064]

[0065] In [Ar-1] to [Ar-6], * indicates the position of carbon that can be bonded to a 5-membered ring containing nitrogen of chemical formula 1, and Y is each independently CR 23 R 24 , NR 25 , O or S.

[0066] The above R 23 Inland R 25 are each independently optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, Rx and R s or may be combined with each other to form an optionally substituted 5- to 7-membered ring.

[0067] The above Ar may be optionally substituted with at least one R". That is, the above Ar is a substituted or unsubstituted ring. When the above Ar is a substituted ring, R" may be bonded to at least one carbon atom in the Ar. In addition, when the above Ar is a substituted ring, R" bonded to at least one carbon atom in the above Ar does not substantially reduce the quenching property of the non-fluorescent compound represented by the above chemical formula 1. Similarly, the above [Ar-1] to [Ar-6] may be optionally substituted with at least one R".

[0068] Various modification examples of Ar in chemical formula 1 can be confirmed from the structures of Dye 1 to Dye 97 attached herein.

[0069] R1 to R6, R' and R" are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s are selected from. The functional groups according to the above definition do not substantially reduce the quenching properties of the non-fluorescent compound represented by the above chemical formula 1.

[0070] In the non-fluorescent compound represented by chemical formula 1, when Ar has the structure of [Ar-1] or [Ar-2], NH4 + , PO4 - and SO3 - (including SO3H, alkyl sulfonate, arylsulfonate, etc.) It is preferable that it does not contain a water-soluble functional group such as. Accordingly, the non-fluorescent compound in which the Ar has the structure of [Ar-1] or [Ar-2] is substantially fat-soluble. That the non-fluorescent compound is substantially fat-soluble means that the non-fluorescent compound exhibits a solubility of 30% or less, 20% or less, or 10% or less in an aqueous solvent, or does not dissolve at all.

[0071] The hydrogen used herein may be protium (1H), deuterium (2H), or tritium (3H), all of which have a mass number of 1.

[0072] The heteroatom used herein means an atom other than carbon and hydrogen, and more specifically, the heteroatom is an atom that can be used to replace carbon in a backbone structure composed of carbon (more specifically, hydrocarbon), and for example, nitrogen, oxygen, sulfur, phosphorus, silicon, or selenium can be used.

[0073] C at our headquarters a -C b The functional group represented by means of a functional group having a to b carbon atoms.

[0074] For example, C a -C b Alkyl refers to a saturated aliphatic functional group including straight-chain alkyl and branched alkyl having a to b carbon atoms. Branched alkyl refers to a saturated aliphatic functional group in which another straight-chain alkyl is bonded to any carbon constituting an unbranched straight-chain alkyl.

[0075] Specifically, alkyl can be methyl, ethyl, n-propyl, i-propyl, n-butyl, s-butyl, i-butyl, t-butyl, pent-1-yl, pent-2-yl, pent-3-yl, 3-methylbut-1-yl, 3-methylbut-2-yl, 2-methylbut-2-yl, 2,2,2-trimethyleth-1-yl, n-hexyl, n-heptyl and n-octyl.

[0076] As used herein, heteroalkyl means a stable straight-chain or branched alkyl having a specified number of total atoms and at least one (e.g., 1 to 15) heteroatom selected from the group consisting of O, N, Si, and S. The carbon and heteroatoms of a heteroalkyl group can be oxidized (e.g., to form ketones, N-oxides, sulfones, etc.), and the nitrogen atom can be quaternized. Non-limiting examples of heteroalkyl groups include -CH2-CH2-O-CH3, -CH2-CH2-NH-CH3, -CH2-CH2-N(CH3)2, -C(=O)-NH-CH2-CH2-NH-CH3, -C(=O)-N(CH3)-CH2-CH2-N(CH3)2, -C(=O)-NH-CH2-CH2-NH-C(=O)-CH2-CH3, -C(=O)-N(CH3)-CH2-CH2-N(CH3)-C(=O)-CH2-CH3, -O-CH2-CH2-CH2-NH(CH3), -O-CH2-CH2-CH2-N(CH3)2, -O-CH2-CH2-CH2-NH-C(=O)-CH2-CH3, -O-CH2-CH2-CH2-N(CH3)-C(=O)-CH2-CH3, -CH2-CH2-CH2-NH(CH3), -O-CH2-CH2-CH2-N(CH3)2, -CH2-CH2-CH2-NH-C(=O)-CH2-CH3, -CH2-CH2-CH2-N(CH3)-C(=O)-CH2-CH3, -CH2-S-CH2-CH3, -CH2-CH2-S(O)-CH3, -NH-CH2-CH2-NH-C(=O)-CH2-CH3, -CH2-CH2-S(O)2-CH3, -CH2-CH2-O-CF3, and -Si(CH3)3.

[0077] In the present invention, alkoxy includes both an -O-(alkyl) group and an -O-(unsubstituted cycloalkyl) group, and specifically includes, but is not limited to, methoxy, ethoxy, propoxy, isopropoxy, n-butoxy, tert-butoxy, sec-butoxy, n-pentoxy, n-hexoxy, 1,2-dimethylbutoxy, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, and the like.

[0078] As used herein, acyl refers to -C(=O)-alkyl, -C(=O)-heteroalkyl, -C(=O)-cycloalkyl (substituted or unsubstituted), -C(=O)-heterocycloalkyl (substituted or unsubstituted), wherein the alkyl, heteroalkyl, cycloalkyl, or heterocycloalkyl bonded to the carbonyl carbon of acyl is as defined herein. Non-limiting examples of acyl groups include -C(=O)CH3, -C(=O)CH2CH3, -C(=O)CH(CH3)2, -C(=O)C(CH3)3, -C(=O)-phenyl (substituted or unsubstituted), -C(=O)-cyclopropyl (substituted or unsubstituted), -C(=O)-cyclobutyl (substituted or unsubstituted), -C(=O)-cyclopentyl (substituted or unsubstituted), -C(=O)-cyclohexyl (substituted or unsubstituted), -C(=O)-pyridyl (substituted or unsubstituted), etc.

[0079] In addition, halogen herein means fluoro (-F), chloro (-Cl), bromo (-Br), or iodo (-I), and alkylhalide or haloalkyl means alkyl substituted with the above-mentioned halogen. For example, halomethyl means methyl (-CH2X, -CHX2, or -CX3) in which at least one of the hydrogens of the methyl is replaced with a halogen. Accordingly, alkylhalide means a functional group in which at least one halogen is bonded to at least one of the carbon atoms constituting the alkyl.

[0080] In this application, aralkyl is a functional group in which aryl is substituted on the carbon of alkyl, -(CH2) n It is a general term for Ar. Examples of aralkyl include benzyl (-CH2C6H5) or phenethyl (-CH2CH2C6H5).

[0081] As used herein, the term "optionally substituted" has the same meaning as the term "substituted or unsubstituted," and means that one or more hydrogen atoms present in any functional group may be independently replaced by a non-hydrogen substituent. However, if any functional group is a substituted functional group, the functional group will not include any substituent or substitution pattern that is sterically unrealizable.

[0082] When any of the functional groups among R1 to R6, R' and R" is a substituted functional group, at least one substituent is bonded to any carbon atom of the functional group (if the functional group does not have a carbon atom, any atom to which the substituent can be bonded (e.g., nitrogen, oxygen or sulfur, etc.)).

[0083] The above substituent is C1-C 40 Alkyl, C1-C 40 Heteroalkyl, C2-C 40 alkenyl, C2-C 40 alkynyl, C3-C 20 Cycloalkyl, C3-C 20 Cycloalkenyl, C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, C2-C 50 Heteroaryl, C5-C 50 Aralkyl, R x and R s is selected from, preferably C1-C 40 Alkyl, C1-C 40 Heteroalkyl, C2-C 40 alkenyl, C2-C 40 alkynyl, R x and R s is selected from, more preferably C1-C 40 Alkyl, C1-C 40 Heteroalkyl, R x and R s is selected from.

[0084] R xis a reactive group or a group having at least one reactive group bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms.

[0085] The above backbone refers to a series of bonds for connecting a reactive group or carrier molecule to a parent molecule represented by chemical formula 1.

[0086] For example, the backbone may be a main chain of an alkyl or heteroalkyl group containing 1 to 40 carbon atoms. In addition, the main chain may include multiple alkyl or heteroalkyl groups linked via an intermediate functional group such as an amide or ester.

[0087] The backbone may comprise at least one heteroatom selected from O, S, N, P, and Si. In addition, the backbone may be linear or non-linear and is composed of any combination of single, double, and triple bonds.

[0088] The above backbone is, for example, alkyl, alkenyl, aryl, heteroaryl, cycloalkyl, heterocycloalkyl, -C(O)-, -C(O)O-, -NR L -, -O-, -S-, -C(O)NR L -, -S(O) O -, -S(O)NR L -, S(O2)NR L -, -P(O) P - and may be selected from the structural formulas (a) to (o) below or may be composed of a combination thereof.

[0089]

[0090] Here, R L Silver hydrogen, C1-C 40 Alkyl and C1-C 40 Selected from heteroalkyl, wherein q is the same or different and independently an integer from 0 to 10, o is an integer from 1 to 2, and p is an integer from 1 to 4.

[0091] The above reactive groups are carboxyl, carboxyl derivatives, carboxylate (-CO2 - ), carboxylates, hydroxyls, dienes, aldehydes, substituted ketones, sulfonyl halides, thiols, unsubstituted amino, primary amino, alkenes, alkynes, halogens, hydrazides, azides, imides, ketenes, isocyanates, thiocyanates, isothiocyanates, epoxides, maleimides, 1,2,4,5-tetrazine derivatives, cycloalkyne derivatives, cycloalkenes, triphosphates and phosphoramidites, substituted thioketones, haloformyl, formyl, acyl, acylamide, acyl azides, organic acid anhydrides, anilines, aziridines, boronates, carbodiimides, diazoalkynes, haloacetamides, imido esters, glycols, halotriazines, hydrazines, acyl halides, alkyl halides and aryl halides. It is a functional group of choice.

[0092] Additionally, the reactive group may not participate in any reaction as it is protected by a protecting group.

[0093] The above protecting group is introduced by chemically converting a reactive group to impart reaction selectivity to at least some of the reactive groups during a continuous chemical or biological reaction process.

[0094] The above protecting groups include alcohol-derived protecting groups, amine-derived protecting groups, carbonyl-derived protecting groups, carboxylic acid-derived protecting groups, phosphate-derived protecting groups, or alkyne-derived protecting groups.

[0095] For example, when the reactive group is hydroxyl, the protecting group may be acetyl, benzoyl, benzyl, β-methoxyethoxymethyl ether, dimethoxytrityl, methoxymethyl ether, methoxytrityl, p-methoxybenzyl ether, p-methoxyphenyl ether, methylthiomethyl ether, silyl ether, trityl or an analog thereof. When the reactive group is amino, the protecting group may be tert-butyl carbamate, benzyl carbamate, acetamide, phthalimide, p-toluenesulfonamide or an analog thereof. R x When is carbonyl or carboxyl, acetal, ketal, dithiane, methyl ester, benzyl ester, tert-butyl ester, silyl ester or analogs thereof may be used. In addition, examples of preferred protecting groups include those described in the following references (Greene et al., PROTECTIVE GROUPS IN ORGANIC SYNTHESIS, John Wiley & Sons, New York, 1991; https: / en.wikipedia.org / wiki / Protecting_group).

[0096] R s is a carrier molecule or a group in which at least one carrier molecule is bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, and the definition of the backbone is R x is the same as

[0097] A carrier molecule refers to a substance that carries a non-fluorescent compound represented by the above chemical formula 1.

[0098] The carrier molecule is an amino acid, a polymer of amino acids, a peptide, a protein, a neurotoxin, a phallotoxin, a cytokine, a toxin, a protease substrate, a protein kinase substrate, an enzyme, an antibody, an antibody fragment, a lectin, a glycoprotein, a histone, an albumin, a lipoprotein, avidin, streptavidin, protein A, protein G, protein L, phycobiliprotein, a fluorescent protein, a hormone, a growth factor, a nucleic acid base, a nucleoside, a nucleotide, a nucleic acid polymer, a nucleotide analog, a nucleoside analog, a nucleoside triphosphate, a deoxynucleoside triphosphate (dNTP), a dideoxynucleoside triphosphate (ddNTP), an organic or inorganic It can be selected from nanoparticles, organic or inorganic microparticles, haptens, carbohydrates, polysaccharides, lipids, ion complexing moieties such as crown ethers, PEG groups, organic polymers and inorganic polymers.

[0099] Additionally, the carrier molecule may not participate in any reaction because it is protected by a protecting group. In this case, the carrier molecule being protected by a protecting group means that a functional group present in the carrier molecule is protected by the protecting group. The definition of the protecting group of the carrier molecule is the same as the protecting group of the reactive group described above.

[0100] In this application, a derivative refers to a similar compound obtained by chemically changing a part of any compound.

[0101] The carboxyl derivative is a functional group that can be converted to carboxyl, and may be an N-hydroxysuccinimide ester, an N-hydroxybenztriazole ester, an acyl halide, an acyl imidazole, a thioester, an alkyl ester, an alkenyl ester, an alkynyl ester, or an aromatic ester.

[0102] The above carboxyl derivative may be optionally substituted and may be, for example, trifluoromethyl ester, pentafluorophenyl ester, p-nitrophenyl ester, tetrafluorophenyl ester, sulfo-succinimidyl ester, sulfodichlorophenyl ester, or sulfotetrafluorophenyl ester.

[0103] The 1,2,4,5-tetrazine derivative may be 3,6-dimethyl-1,2,4,5-tetrazine, 3,6-diphenyl-1,2,4,5-tetrazine or 3-methyl-6-phenyl-1,2,4,5-tetrazine.

[0104] Cycloalkyne derivatives can be compounds that participate in bipolar cycloaddition, inverse-electron demand Diels-Alder, or strain-promoted azide-alkyne cycloaddition (SPAAC) reactions. For example, cycloalkyne derivatives that participate in SPAAC reactions include cyclooctynes ​​such as OCT, COMBO (ALO), MOFO, DIFO, DIBO, BARAC, DIBAC (ADIBO), DBCO, DIMAC, BCN, or TMTH.

[0105] In addition, examples of any derivatives specified herein can be found in literature known in the relevant technical field.

[0106] A diene is an alkene or alkyne capable of undergoing a Diels-Alder reaction with a diene, specifically sp 2- It can be an alkene or alkene with an electron withdrawing group directly connected to a hybridized carbon or sp-hybridized carbon.

[0107] An electron-withdrawing group is a functional group that tends to attract electrons through an inductive effect or a resonance effect, and may also be referred to as a deactivating group. Examples of such electron-withdrawing groups include trifluoromethylsulfonyl (-SO2CF3), substituted or unsubstituted ammonium (-NR3 + ), nitro, sulfonic acid (-SO3H), sulfonyl (-SO2R), nitrile, trihalomethyl (-CF3, -CCl3, -CBr3, -CI3), haloformyl (-COCl, -COBr, -COI), formyl (-CHO), acyl (-COR), carboxyl (-CO2H), substituted ester (-CO2R), substituted or unsubstituted aminocarbonyl (-CONR2), and nitroso (-N=O). In addition, the electron withdrawing group may further include a functional group that tends to attract electrons other than the functional groups exemplified above, unless otherwise defined herein.

[0108] R7 and R8 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from.

[0109] X is CR 20 R 21 , NR 22 , O or S. X is CR 20 R 21 If , R 20 and R 21 are each independently optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x and R s is selected from.

[0110] X is NR 22 If , R 22 are each independently optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x or R s am.

[0111] n is an integer from 0 to 5. When n is 0, one R' is present, and when n is 1 or greater, multiple R's are present. If multiple R's are present in the polymethine due to n being 1 or greater, they are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from.

[0112] Two adjacent groups among R1 to R6 can combine with each other to form an optionally substituted 5- to 7-membered ring.

[0113] The ring formed by two adjacent groups among R1 to R6 bonded to each other may be an aliphatic ring (cycloalkyl, heterocycloalkyl) or an aromatic ring (aryl, heteroaryl). In addition, the ring may be a single ring or a multi-ring, and when the ring is a multi-ring, it may be an aliphatic-aliphatic mixed ring, an aliphatic-aromatic mixed ring, or an aromatic-aromatic mixed ring. As described above, the mixed ring means a multi-ring (preferably 2 to 6 rings) in which identical or different rings are connected by a fusion or covalent bond (for example, a single bond).

[0114] The ring formed by combining two adjacent groups among R1 to R6 is C1-C 40 Alkyl, C1-C 40 Heteroalkyl, C2-C 40 alkenyl, C2-C 40 alkynyl, C3-C 20 Cycloalkyl, C3-C 20 Cycloalkenyl, C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, C2-C 50 Heteroaryl, C5-C 50 Aralkyl, R x and R s It can be substituted with a functional group selected from .

[0115] A variation in which two adjacent groups among R1 to R6 are bonded to each other to form a 5- to 7-membered ring can be confirmed from the structures of Dye 1 to Dye 97 attached herein.

[0116] When the above Ar is substituted with multiple R", two adjacent groups among R" can combine with each other to form an optionally substituted 5- to 7-membered ring.

[0117] The ring formed by two adjacent groups of "R" bonded to each other may be an aliphatic ring (cycloalkyl, heterocycloalkyl) or an aromatic ring (aryl, heteroaryl). In addition, the ring may be a single ring or a multi-ring, and when the ring is a multi-ring, it may be an aliphatic-aliphatic mixed ring, an aliphatic-aromatic mixed ring, or an aromatic-aromatic mixed ring. As described above, the mixed ring means a multi-ring (preferably 2 to 6 rings) in which identical or different rings are connected by a fusion or covalent bond (for example, a single bond).

[0118] The ring formed by two adjacent groups of R" is C1-C 40 Alkyl, C1-C 40 Heteroalkyl, C2-C 40 alkenyl, C2-C 40 alkynyl, C3-C 20 Cycloalkyl, C3-C 20 Cycloalkenyl, C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, C2-C 50 Heteroaryl, C5-C 50 Aralkyl, R x and R s It can be substituted with a functional group selected from .

[0119] Variants in which two adjacent groups of "R" are bonded to each other to form a five- to seven-membered ring can be identified from the structures of Dye 1 to Dye 97 attached herein.

[0120] R 20 Inland R 22 Two adjacent groups may combine with each other to form an optionally substituted five- to seven-membered ring.

[0121] R 20 Inland R 22The ring formed by combining two adjacent groups may be an aliphatic ring (cycloalkyl, heterocycloalkyl) or an aromatic ring (aryl, heteroaryl). In addition, the ring may be a single ring or a multi-ring, and when the ring is a multi-ring, it may be an aliphatic-aliphatic mixed ring, an aliphatic-aromatic mixed ring, or an aromatic-aromatic mixed ring. As described above, the mixed ring means a multi-ring (preferably 2 to 6 rings) in which identical or different rings are connected by a fusion or covalent bond (e.g., a single bond).

[0122] R 20 Inland R 22 The ring formed by the bonding of two adjacent groups is C1-C 40 Alkyl, C1-C 40 Heteroalkyl, C2-C 40 alkenyl, C2-C 40 alkynyl, C3-C 20 Cycloalkyl, C3-C 20 Cycloalkenyl, C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, C2-C 50 Heteroaryl, C5-C 50 It may be substituted with a functional group selected from aralkyl, Rx and Rs.

[0123] R 20 Inland R 22 Variants in which two adjacent groups are bonded to form a five- to seven-membered ring can be identified from the structures of Dye 1 to Dye 97 attached herein.

[0124] In this way, when two adjacent groups among the non-fluorescent compounds represented by the above chemical formula 1 are combined to form a ring, the ring may be phenyl, naphthyl, carbazole, fluorene, dibenzofuran, dibenzothiophene, fluoranthene, etc., but is not necessarily limited thereto.

[0125] In addition, the non-fluorescent compound represented by the above chemical formula 1 has at least one R X or R S It is characterized by the existence of .

[0126] The non-fluorescent compound represented by Chemical Formula 1 may further include a counter ion. The counter ion may be an organic or inorganic anion and may be appropriately selected considering the solubility and stability of the quencher.

[0127] Specifically, inorganic acid anions such as phosphoric acid hexafluoride ion, halogen ion, phosphoric acid ion, perchlorate ion, periodate ion, antimony hexafluoride ion, tartaric acid hexafluoride ion, fluoroboric acid ion, and tetrafluoride ion, and organic acid ions such as thiocyanate ion, benzenesulfonic acid ion, naphthalenesulfonic acid ion, p-toluenesulfonic acid ion, alkylsulfonic acid ion, benzenecarboxylic acid ion, alkylcarboxylic acid ion, trihaloalkylcarboxylic acid ion, alkylsulfonic acid ion, trihaloalkylsulfonic acid ion, and nicotinic acid ion can be used as counter ions. In addition, metal compound ions such as bisphenylditol, thiobisphenol chelate, and bisdiol-α-diketone, metal ions such as sodium and potassium, and quaternary ammonium salts can also be used as counter ions.

[0128] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 2. The non-fluorescent compound represented by the following chemical formula 2 has a structure in which Ar is [Ar-1] among the non-fluorescent compounds represented by the above chemical formula 1.

[0129] [Chemical Formula 2]

[0130]

[0131] In chemical formula 2, R1 to R8, R', R x , R s , n, X, R 20 Inland R 22The definition is the same as in Chemical Formula 1, and is the same as in Chemical Formula 1 unless otherwise defined.

[0132] R9 to R 12 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, Rx and R s is selected from.

[0133] R9 to R 12 Two adjacent groups may combine with each other to form an optionally substituted five- to seven-membered ring.

[0134] The non-fluorescent compound represented by the above chemical formula 2 contains at least one R X or R S exists.

[0135] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 3. The non-fluorescent compound represented by the following chemical formula 2 may be R among the non-fluorescent compounds represented by the above chemical formula 3. 10 and R 11 This has a structure in which it combines to form ring A.

[0136] [Chemical Formula 3]

[0137]

[0138] In chemical formula 3, R1 to R8, R', R", R x , R s , n, X, R 20 Inland R 22 The definition is the same as in Chemical Formula 1, and is the same as in Chemical Formula 1 unless otherwise defined.

[0139] Ring A is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 An aliphatic-aromatic mixed ring, wherein ring A is optionally substituted with at least one R".

[0140] R9 and R 12 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from.

[0141] R", R9 and R 12 Two adjacent groups may combine with each other to form an optionally substituted five- to seven-membered ring.

[0142] The non-fluorescent compound represented by the above chemical formula 3 has at least one R X or R Sexists.

[0143] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 4. The non-fluorescent compound represented by the following chemical formula 4 is R among the non-fluorescent compounds represented by the above chemical formula 2. 11 and R 12 It has a structure in which it combines to form ring B.

[0144] [Chemical Formula 4]

[0145]

[0146] In chemical formula 4, R1 to R8, R', R", R x , R s , n, X, R 20 Inland R 22 The definition is the same as in Chemical Formula 1, and is the same as in Chemical Formula 1 unless otherwise defined.

[0147] Ring B is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 An aliphatic-aromatic mixed ring, wherein ring B is optionally substituted with at least one R".

[0148] R9 and R 10 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from.

[0149] R" and R 10 can combine with each other to form optionally substituted 5- to 7-membered rings.

[0150] The non-fluorescent compound represented by the above chemical formula 4 has at least one R X or R S exists.

[0151] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 5. The non-fluorescent compound represented by the following chemical formula 5 is a non-fluorescent compound represented by the above chemical formula 2, wherein R9 and R 10 This has a structure in which it combines to form a ring C.

[0152] [Chemical Formula 5]

[0153]

[0154] In chemical formula 5, R1 to R8, R', R", R x , R s , n, X, R 20 Inland R 22 The definition is the same as in Chemical Formula 1, and is the same as in Chemical Formula 1 unless otherwise defined.

[0155] Ring C is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 An aliphatic-aromatic mixed ring, wherein ring C is optionally substituted with at least one R".

[0156] R 11 and R 12 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from.

[0157] R" and R 11 can combine with each other to form optionally substituted 5- to 7-membered rings.

[0158] The non-fluorescent compound represented by the above chemical formula 5 has at least one R X or R S exists.

[0159] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 6. The non-fluorescent compound represented by the following chemical formula 6 has a structure in which Ar is a naphthalene ring conjugated to X among the non-fluorescent compounds represented by the above chemical formula 1.

[0160] [Chemical Formula 6]

[0161]

[0162] In chemical formula 6, R1 to R8, R', R x , R s The definitions for and n are the same as in Chemical Formula 1, and are the same as in Chemical Formula 1 unless otherwise defined.

[0163] R D are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from , and o is an integer from 0 to 6.

[0164] The non-fluorescent compound represented by the above chemical formula 6 has at least one R X or R S exists.

[0165] The non-fluorescent compound represented by chemical formula 6 is NH4 + , PO4 - and SO3 - It is preferable that it does not contain a water-soluble functional group such as (including SO3H, alkyl sulfonate, arylsulfonate, etc.). Accordingly, the non-fluorescent compound represented by the above chemical formula 6 is substantially fat-soluble. That the non-fluorescent compound is substantially fat-soluble means that the non-fluorescent compound exhibits a solubility of 30% or less, 20% or less, or 10% or less in an aqueous solvent, or does not dissolve at all.

[0166] In another embodiment, the non-fluorescent compound may be represented by the following chemical formula 7. The non-fluorescent compound represented by the following chemical formula 7 has a structure in which Ar among the non-fluorescent compounds represented by the above chemical formula 1 has a structure represented by the following chemical formula 8.

[0167] [Chemical Formula 7]

[0168]

[0169] In chemical formula 7, R1 to R7, R', R x , R s , n, X, R 20 Inland R 22 The definition is the same as in Chemical Formula 1, and is the same as in Chemical Formula 1 unless otherwise defined.

[0170] a and b of the above chemical formula 7 are R of the following chemical formula 8 31 Inland R 35 It is joined to two adjacent ones.

[0171] [Chemical Formula 8]

[0172]

[0173] R 31 Inland R 35Among the above, a and b of the chemical formula 7 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from.

[0174] R31 and R 35 Among the two adjacent groups that are not bonded to a and b of the above chemical formula 7, the two adjacent groups can combine with each other to form an optionally substituted 5- to 7-membered ring.

[0175] Q is hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from.

[0176] The non-fluorescent compound represented by the above chemical formula 7 has at least one R X or R S exists.

[0177] Specific examples of the compounds defined herein are as follows. However, the following exemplary compounds are intended to aid understanding of the compounds defined herein and are not intended to limit the scope of the compounds defined herein. Any compounds deemed equivalent to the following exemplary compounds, within the scope of the compounds defined herein, can be expected to exhibit the effects of the compounds defined herein.

[0178] In addition, the remaining exemplary compounds, excluding compounds whose synthetic steps are described in detail through the manufacturing examples disclosed herein, can also be synthesized by referring to the manufacturing examples disclosed herein or by using a synthetic method known in the art with reference to the contents defined herein.

[0179]

[0180]

[0181]

[0182]

[0183]

[0184]

[0185]

[0186]

[0187]

[0188]

[0189]

[0190]

[0191] Uses of non-fluorescent compounds

[0192] The present invention relates to a non-fluorescent compound useful as a quencher for a fluorescent compound exhibiting luminescence properties at an excited energy level and various uses thereof. According to another aspect of the present invention, various uses of a non-fluorescent compound capable of quenching the luminescence properties of a fluorescent compound by static quenching and dynamic quenching are provided.

[0193] In one embodiment, a conjugate comprising a non-fluorescent compound as defined herein as a quencher may be provided.

[0194] The above conjugate can be used for biomolecule labeling. The conjugate can target biomolecules such as antibodies, lipids, proteins, peptides, carbohydrates, and nucleic acids (including nucleotides and nucleosides). Specific examples of lipids include fatty acids, phospholipids, and lipopolysaccharides, and specific examples of carbohydrates include monosaccharides, disaccharides, and polysaccharides (e.g., dextran).

[0195] The conjugate may be a nucleotide conjugate, a probe, a primer, and / or a peptide. The non-fluorescent compound may be bound to any terminal (5'-terminal or 3'-terminal) or any position within the conjugate.

[0196] If the conjugate is a nucleotide conjugate, the conjugate may include an oligonucleotide.

[0197] The above oligonucleotide refers to a polymer of 1 to several hundred nucleotides. The phosphodiester bond in the oligonucleotide may be modified or replaced with methylphosphonate, phosphorothioate (PTO), boranophosphate, phosphoryl guanidine, guanidinopropyl phosphoramidate, thiazole, guadiinium, etc. In addition, the oligonucleotide may include one or more modified nucleotides. For example, the modified nucleotide may include PNA, BNA (e.g., LNA, ENA, etc.), HNA, ANA, CeNA, and GNA with modified sugars, or cases where any substituent (e.g., MOE, alkyl, halogen, etc.) is introduced into the sugar.

[0198] Additionally, modified nucleotides and nucleosides may include nucleobases modified from adenine (A), guanine (G), thymine (T), cytosine (C), uracil (U), for example, inosine, xanthine, hypoxanthine, nubularine, isoguanisine, tubercidine, 2-aminoadenine, 2-haloadenine, 2-alkyladenine, 2-methylaminoadenine, 6-methyladenine, 8-haloadenine, 8-aminoadenine, 8-thioadenine, diazaadenine, 8-hydroxyadenine and other substituted adenines, 5-halouracil, 4-thiouracil, 5-trifluoromethyluracil, pseudouracil, 2-thiouracil, 5-halouracil and other substituted uracils, 5-halocytosine, 5-trifluorocytosine, 6-azacytosine and other substituted cytosines, 2-thiothymine, 6-azathimine and other substituted thymines, 8-haloguanine, 8-aminoguanine, 8-thioguanine, 8-thioalkylguanine, 8-hydroxyguanine, 8-azaguanine, 7-deazaguanine, 7-methylguanine and other substituted guanines, pyrazolo[3,4-d]pyrimidine, 2,6-diaminopurine, phenoxazine, 2-aminopurine, 3-nitropyrrole, 5-hydroxybutynyluridine, Super A®, Super G®, Super T®, Super D™, and the like.

[0199] Examples of modified nucleobases can also be found in the following references (US Pat. Nos. 11,155,713; Current Topics in Medicinal Chemistry, Volume 7, Number 7, Wojciechowski, Filip, E. Hudson, Robert H, 2007, pp. 667-679).

[0200] A nucleobase as defined herein is meant to include a modified nucleobase.

[0201] An oligonucleotide labeled with one non-fluorescent compound or fluorescent compound may be referred to as a single-labeled oligonucleotide, for example, an oligonucleotide in which the non-fluorescent compound is labeled at the 3'-end.

[0202] Additionally, the conjugate may include a quencher and a fluorophore comprising a non-fluorescent compound as defined herein. Here, the fluorophore may be a known fluorescent compound suitable for biomolecule labeling. The fluorescent compound may be attached to any terminal (5'-terminal or 3'-terminal) or any position within the conjugate.

[0203] An oligonucleotide labeled with two non-fluorescent compounds or fluorescent compounds may be referred to as a dual-labeled oligonucleotide, for example, an oligonucleotide in which the fluorescent compound is labeled at the 5'-end and the non-fluorescent compound is labeled at the 3'-end.

[0204] As the fluorescent compound, at least one selected from coumarin, cyanine, bodipy, floracene, rhodamine, pyrene, carbopyronine, oxazine, xanthen, thioxanthen, acridine and / or derivatives thereof may be used.

[0205] A more specific example of the above fluorescent compound is 6-FAM. TM , TET TM , JOE TM , VIC®, HEX TM , NED TM , PET®, ROX TM , TAMRA TM , TET TM, Texas Red®, SUN, MAX, ABY, JUN, LIZ, TAZ, CAL Fluor® Gold 540, CAL Fluor® Orange 560, CAL Fluor® Red 590, CAL Fluor® Red 610, CAL Fluor® Red 635, Cy® (cyanine) 3, Cy® 3.5, Cy® 5, Cy® 5.5, Cy® 7, Cy® 7.5, Quasar® 570, Quasar® 670, Quasar® 705, Rhodamine Green TM , Rhodamine Red TM , LightCycler® Cyan 500, LightCycler® Red 610, LightCycler® Red 640, LightCycler® Red 670, LightCycler® Red 705, Oregon Green® 488, Oregon Green® 500, Oregon Green® 514, the Alexa Fluor® dyes 350, 405, 488, 532, 546, 555, 568, 594, 610, 647, 680 and Alexa Fluor® 750, the BODIPY® dyes, Epoch Blue, AMCA, Marina Blue®, Pacific Blue TM , Pacific Green TM , Pacific Orange TM , Yakima Yellow TM , the ATTO dyes 390, 425, 465, 488, 495, 514, 520, 532, Rho6G, 542, 550, 565, Rho3B, Rho11, Rho12, Thio12, Rho101, 590, 594, Rho13, 610, 620, Rho14, 633, 643, 647, 647N, 655, Oxa12, 665, 680, 700, 725, and ATTO 740, Texas red, Oyster 645, SFC TM -V, SFCTM -N, SFC TM 574, SFC TM 647, SFC TM -C610, SFC TM 620, SFC TM 670, SFC TM 705, Chamel TM 560, Chamel TM 610, Chamel TM 670 and Chamel TM There are 705, etc.

[0206] The conjugate may comprise a first quencher comprising a non-fluorescent compound as defined herein; a second quencher selected from azo, coumarin, cyanine, bodipy, phlorsane, rhodamine, pyrene, carbopyronine, benzo[c,d]indole, oxazine, xanthene, thioxanthene, acridine and derivatives thereof; and a fluorophore.

[0207] The first quencher, the second quencher and the fluorophore can be bonded to any terminal (5'-terminal or 3'-terminal) or any position within the conjugate.

[0208] An oligonucleotide labeled with three non-fluorescent or fluorescent compounds may be referred to as a triple-labeled oligonucleotide, for example, an oligonucleotide in which the fluorescent compound is labeled at the 5'-end, the first quencher is labeled at the 3'-end, and the second quencher is inserted between the oligonucleotides.

[0209] As the second quencher, at least one selected from azo, coumarin, cyanine, bodipy, florcain, rhodamine, pyrene, carbopyronine, benzo[c,d]indole, oxazine, xanthen, thioxanthen, acridine and derivatives thereof can be used.

[0210] More specific examples of the second quencher include dabcyl and Eclipse.TM , Black Hole Quencher TM BHQ0(BHQnova), Black Hole Quencher TM BHQ1, Black Hole Quencher TM BHQ2, Black Hole Quencher TM BHQ3, BlackBerry TM Quencher 650 (BBQ650 TM ), Iowa Black TM FQ(IABkFQ), SFC TM Q1, SFC TM Q2, Iowa Black TM RQ-n1, Iowa Black TM RQ-n2 and Iowa Black TM RQSp, TAMRA, Deep Dark Quencher I (DDQ I), Deep Dark Quencher II (DDQ II), QXL TM 520, QXL TM 570, QXL TM 610, QXL TM 670, IRQXL TM , IRDye TM , QC-1, QSY TM , QSY TM 2, BMN-Q460, BMN-Q535, BMN-Q1, BMN-Q2, BMN-Q590, BMN-Q620, BMN-Q651, etc.

[0211] Additionally, the conjugate may further include a minor groove binder (MGB) to enhance binding affinity with nucleic acids. Using a conjugate further including MGB can enhance the PCR amplification effect.

[0212] The conjugates defined herein can be utilized in a variety of chemical and biological fields. They are particularly useful for, but not limited to, real-time polymerase chain reaction (PCR) and microassays.

[0213] In another embodiment, a composition for detecting a nucleic acid comprising a conjugate as defined herein may be provided.

[0214] A composition for detecting nucleic acids according to one embodiment of the present invention may further include an enzyme, a solvent (buffer, etc.), and other reagents for reaction with a target nucleic acid together with the conjugate defined herein.

[0215] Here, a buffer selected from the group consisting of a phosphate buffer, a carbonate buffer, and a Tris buffer, an organic solvent selected from dimethyl sulfoxide, dimethylformamide, dichloromethane, methanol, ethanol, and acetonitrile, or water can be used as the solvent, and it is possible to control the solubility by introducing various functional groups to the quencher depending on the type of solvent.

[0216] In another embodiment, a support for detecting nucleic acids may be provided, comprising a quencher comprising a non-fluorescent compound as defined herein, a support, and a linker connecting the quencher and the support. A biomolecule (nucleic acid) in a sample may be immobilized on the support through interaction with the quencher immobilized on the support.

[0217] The support may be made of at least one selected from glass (e.g., CPG), cellulose, nylon, acrylamide gel, dextran, polystyrene, alginate, collagen, peptide, fibrin, hyaluronic acid, agarose, polyhydroxyethyl methacrylate, polyvinyl alcohol, polyethylene glycol, polyethylene oxide, polyethylene glycol diacrylate, gelatin, matrigel, polylactic acid, carboxymethylcellulose, dextran, chitosan, latex, and sepharose, and may be in the form of a bead or membrane.

[0218] The above connecting portion is a portion that connects the quencher and the support, and any material that can connect the quencher and the support can be used as the connecting portion intended herein.

[0219] For example, the above linking member may be substituted or unsubstituted C1-C 30 Alkyl, substituted or unsubstituted C3-C 30 Cycloalkyl, substituted or unsubstituted C2-C containing at least one heteroatom 30 Heteroalkyl, substituted or unsubstituted C2-C containing at least one heteroatom 30 Heterocycloalkyl, substituted or unsubstituted C2-C 30 Alkenyl, substituted or unsubstituted C6-C 30 Aryl, substituted or unsubstituted C3-C 30 It can be selected from heteroaryl, amide (-CONH-), ester (-COO-), ketone (-CO-), nucleoside, and any combination thereof. The linking moiety only connects the quencher and the support and does not substantially affect other reactions or fluorescence and quenching actions of the quencher or the fluorophore.

[0220] An example of a connection structure between the support and the quencher via the above-mentioned connecting portion is as follows. In the above examples, “Quencher” means “quencher (photon quencher)” and “dye” means a fluorescent substance.

[0221] [Connection Structure 1]

[0222]

[0223] [Connection Structure 2]

[0224]

[0225] [Connection Structure 3]

[0226]

[0227] [Connection Structure 4]

[0228]

[0229] [Connection Structure 5]

[0230]

[0231] [Connection Structure 6]

[0232]

[0233] [Connection Structure 7]

[0234]

[0235] [Connection Structure 8]

[0236]

[0237] [Connection Structure 9]

[0238]

[0239] [Connection Structure 10]

[0240]

[0241] [Connection Structure 11]

[0242]

[0243] [Connection Structure 12]

[0244]

[0245] [Connection Structure 13]

[0246]

[0247]

[0248] Nucleic acid detection method

[0249] According to another aspect of the present invention, a method of labeling a nucleic acid, which is a target biomolecule, is provided using a conjugate comprising a non-fluorescent compound and a fluorescent compound as defined herein.

[0250] Additionally, depending on the type of target biomolecule, a method for labeling a biomolecule utilizing target-specific interactions may be implemented by introducing an appropriate reactive group into a non-fluorescent compound and / or a fluorescent compound. Furthermore, a method for identifying a biomolecule labeled with the conjugate defined herein through electrophoresis may also be implemented.

[0251] In one embodiment, the nucleic acid detection method may include: (a) preparing a reaction mixture comprising a target nucleic acid, a reagent necessary for amplifying the target nucleic acid, and a conjugate as defined herein; (b) amplifying the target nucleic acid in the reaction mixture; and (c) measuring the fluorescence intensity of the reaction mixture.

[0252] The conjugate used in the above examples comprises a quencher and a fluorophore, at least including a non-fluorescent compound as defined herein.

[0253] The above step (b) may include (b-1) a step in which a nucleotide conjugate hybridized to the target nucleic acid is extended by a polymerase; (b-2) a step in which a quencher and a fluorophore of the nucleotide conjugate are separated from the target nucleic acid by the exonuclease activity of the polymerase; and (b-3) a step in which the fluorophore separated from the quencher emits fluorescence.

[0254] In addition, in the step (b), the target nucleic acid may be subjected to strand displacement amplification (SDA), polymerase chain reaction (PCR), reverse transcription polymerase chain reaction (RT-PCR), real-time polymerase chain reaction, allele-specific polymerase chain reaction, ligase chain reaction (LCR), rolling circle amplification (RCA), isothermal multiple displacement amplification (IMDA), recombinase polymerase amplification (RPA), self-sustained sequence replication (3SR), single primer isothermal amplification (SPIA), multiple displacement amplification (MDA), whole genome amplification (WGA). Genome Amplification), Cross-priming Amplification (CPA), Signal Mediated Amplification of RNA Technology (SMART), Transcription Mediated Amplification (TMA), Nucleic Acid Sequence Based Amplification (NASBA), Loop-mediated isothermal amplification (LAMP,It can be amplified by a method selected from Loop-mediated Isothermal Amplification), and Helicase Dependent Amplification (HDA).

[0255] In addition, the method may further include a step (d) of measuring the amplification amount of the target nucleic acid from the fluorescence intensity measured in the above step (c).

[0256]

[0257] Specific embodiments of the present invention are presented below. However, the embodiments described below are merely intended to specifically illustrate or explain the present invention and should not be construed as limiting the present invention.

[0258]

[0259] Synthesis example. Synthesis of non-fluorescent compounds

[0260] Synthesis of Dye 1

[0261]

[0262]

[0263] Synthesis of intermediate 1-1

[0264] Intermediate 1-1 was synthesized with reference to Dyes and Pigments, 2012, vol. 93, # 1-3, p. 1506 - 1511.

[0265]

[0266] Synthesis of intermediate 1-1

[0267] Intermediates 1-2 were synthesized with reference to Journal of Photochemistry and Photobiology A: Chemistry 2008, vol. 200, # 2-3, p.438-444.

[0268]

[0269] Synthesis of Dye 1

[0270] Intermediate 1-1 (2.0 g, 4.8 mmol), intermediate 1-2 (1.95 g, 4.8 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 1 (1.2 g).

[0271] The obtained Dye 1 1 H-NMR is as follows.

[0272] 1 H-NMR (400 MHz, DMSO-d6) δ 8.72 (t, 1H, J = 12.8 Hz), 8.52 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 8.4 Hz) 7.2 Hz), 7.79 (d, 1H, J = 8.4 Hz), 7.68 (t, 1H, J = 8.4 Hz), 7.57-7.55 (m, 2H), 7.45-7.29 (m, 2H), 7.00 (d, 1H, J = 13.6 Hz), 6.83 (d, 1H, J = 12.8 Hz), 4.50 (t, 2H, J = 7.6 Hz), 3.82 (s, 3H), 2.54 (m, 2H), 2.03-1.77 (m, 6H)

[0273]

[0274] Synthesis of Dye 2

[0275]

[0276]

[0277] Synthesis of intermediate 2-1

[0278] Intermediate 2-1 was synthesized with reference to Organic and Biomolecular Chemistry, 2011, vol. 9, # 11, p. 4199 - 4204.

[0279]

[0280] Synthesis of Dye 2

[0281] In a 100 mL single-necked reactor, intermediate 2-1 (3.0 g, 6.9 mmol), intermediate 1-2 (2.81 g, 6.9 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 2 (2.2 g).

[0282] The obtained Dye 2 1 H-NMR is as follows.

[0283] 1 H-NMR (400 MHz, DMSO-d6) δ 8.75 (t, 1H, J = 12.8 Hz), 8.50 (d, 1H, J = 8.0 Hz), 8.39 (d, 1H, J = 8.21 (d, 1H, J = 8.4 Hz), 8.00 (t, 1H, J = 8.4 Hz) 7.2 Hz), 7.76 (d, 1H, J = 8.4 Hz), 7.68 (t, 1H, J = 8.4 Hz), 7.59-7.51 (m, 2H), 7.49-7.25 (m, 2H), 7.01 (d, 1H, J = 13.6 Hz), 6.88 (d, 1H, J = 12.8 Hz), 4.51 (t, 2H, J = 7.6 Hz), 3.80 (s, 3H), 2.53 (m, 2H), 2.10-1.76 (m, 6H)

[0284]

[0285] Synthesis of Dye 3

[0286]

[0287]

[0288] Synthesis of intermediate 3-1

[0289] Intermediate 3-1 was synthesized with reference to Angewandte Chemie - International Edition, 2020, vol. 59, # 10, p. 3948 - 3951.

[0290]

[0291] Synthesis of intermediate 3-2

[0292] In a 250 mL single-necked reactor, add intermediate 3-1 (5.0 g, 17 mmol), N,N-diphenylformamidine (4.1 g, 21 mmol), and acetic anhydride (40 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 3-2.

[0293]

[0294] Synthesis of Dye 3

[0295] In a 100 mL single-necked reactor, intermediate 3-2 (2.0 g, 4.6 mmol), intermediate 1-2 (1.89 g, 4.6 mmol), and pyridine (20 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 3 (0.8 g).

[0296] The obtained Dye 3 1 H-NMR is as follows.

[0297] 1 H-NMR (400 MHz, DMSO-d6) δ 8.70 (t, 1H, J = 12.8 Hz), 8.48 (d, 1H, J = 8.0 Hz), 8.37 (d, 1H, J = 8.21 (d, 1H, J = 8.4 Hz), 8.00 (t, 1H, J = 8.4 Hz) 7.2 Hz), 7.74 (d, 1H, J = 8.4 Hz), 7.66 (t, 1H, J = 8.4 Hz), 7.55-7.50 (m, 2H), 7.49-7.25 (m, 2H), 7.00 (d, 1H, J = 13.6 Hz), 6.86 (d, 1H, J = 12.8 Hz), 4.50 (t, 2H, J = 7.6 Hz), 3.88 (s, 6H), 2.51 (m, 2H), 2.10-1.75 (m, 6H)

[0298]

[0299] Synthesis of Dye 4

[0300]

[0301]

[0302] Synthesis of intermediate 4-1

[0303] Intermediate 4-1 was synthesized with reference to Journal of the American Chemical Society, 2001, vol. 123, # 2, p. 361 - 362.

[0304]

[0305] Synthesis of intermediate 4-2

[0306] Intermediate 4-1 (5.0 g, 17 mmol), intermediate 1-2 (4.1 g, 21 mmol), and pyridine (50 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize intermediate 4-2.

[0307]

[0308] Synthesis of Dye 4

[0309] Intermediate 4-2 (2.7 g, 4.2 mmol), HSTU (O-(N-Succinimidyl)-N,N,N',N'-tetramethyl uronium hexafluoro phosphate) (1.81 g, 5.0 mmol), triethylamine (1.76 mL, 12.6 mmol), and dimethylformamide (27 mL) were added to a 100 mL single-necked reactor and stirred at room temperature for 30 minutes. After concentration, the mixture was purified by column chromatography to synthesize Dye 4 (2.1 g).

[0310] The obtained Dye 4 1 H-NMR is as follows.

[0311] 1H-NMR (400 MHz, DMSO-d6) δ 8.77 (t, 1H, J = 12.8 Hz), 8.54 (d, 1H, J = 8.0 Hz), 8.38 (d, 1H, J = 8.29 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 7.2 Hz), 7.71 (d, 1H, J = 8.4 Hz), 7.65 (t, 1H, J = 8.4 Hz), 7.61-7.52 (m, 2H), 7.47-7.15 (m, 2H), 7.00 (d, 1H, J = 13.6 Hz), 6.87 (d, 1H, J = 12.8 Hz), 4.50 (t, 2H, J = 7.6 Hz), 3.90 (s, 4H), 3.82 (s, 3H), 2.53 (m, 2H), 2.12 (s, 6H), 2.10-1.76 (m, 6H)

[0312]

[0313] Synthesis of Dye 5

[0314]

[0315]

[0316] Synthesis of intermediate 5-1

[0317] Intermediate 5-1 was synthesized with reference to Journal of Medicinal Chemistry, 2022, vol. 65, # 1, p. 811 - 823.

[0318]

[0319] Synthesis of Dye 5

[0320] In a 100 mL single-necked reactor, intermediate 5-1 (3.0 g, 6.4 mmol), intermediate 1-2 (2.6 g, 6.4 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 5 (1.7 g).

[0321] The obtained Dye 5 1 H-NMR is as follows.

[0322] 1 H-NMR (400 MHz, DMSO-d6) δ 8.56 (d, 1H, J = 8.0 Hz), 8.49 (t, 2H, J = 15.6 Hz), 8.33 (d, 1H, J = 8.30 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.00 (t, 1H, J = 7.2 Hz), 7.75 (d, 1H, J = 8.4 Hz), 7.63 (t, 1H, J = 8.4 Hz), 7.60-7.50 (m, 2H), 7.45-7.17 (m, 2H), 6.90 (t, 1H, J = 13.6 Hz), 6.36 (d, 2H, J = 13.6 Hz), 4.52 (t, 2H, J = 7.6 Hz), 3.80 (s, 3H), 2.53 (m, 2H), 2.12 (s, 6H), 2.10-1.76 (m, 6H)

[0323]

[0324] Synthesis of Dye 6

[0325]

[0326]

[0327] Synthesis of intermediate 6-1

[0328] Intermediate 6-1 was synthesized with reference to Journal of the American Chemical Society, 2011, vol. 133, # 1, p. 51 - 55.

[0329]

[0330] Synthesis of intermediate 6-2

[0331] Intermediate 6-2 was synthesized with reference to Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0332]

[0333] Synthesis of Dye 6

[0334] Intermediate 6-1 (2.0 g, 3.7 mmol), intermediate 6-2 (1.1 g, 3.7 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 6. (1.1 g)

[0335] The obtained Dye 6 1 H-NMR is as follows.

[0336] 1 H-NMR (400 MHz, DMSO-d6) δ 8.76 (t, 1H, J = 12.8 Hz), 8.51 (d, 1H, J = 8.0 Hz), 8.37 (d, 1H, J = 8.0 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.04 (t, 1H, J = 7.2 Hz), 7.70 (d, 1H, J = 8.4 Hz), 7.62 (t, 1H, J = 8.4 Hz), 7.59-7.50 (m, 2H), 7.45-7.13 (m, 2H), 6.98 (d, 1H, J = 13.6 Hz), 6.86 (d, 1H, J = 12.8 Hz), 4.26 (t, 2H, J = 7.6 Hz), 3.85 (s, 3H), 2.51 (m, 2H), 2.13 (s, 6H), 2.10-1.75 (m, 6H)

[0337]

[0338] Synthesis of Dye 7

[0339]

[0340]

[0341] Synthesis of intermediate 7-1

[0342] In a 250 mL single-necked reactor, add intermediate 6-2 (5.0 g, 16 mmol), N,N-diphenylformamidine (3.8 g, 21 mmol), and acetic anhydride (40 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 7-1.

[0343]

[0344] Synthesis of intermediate 7-2

[0345] Intermediate 7-2 was synthesized with reference to WO2022-191485 A1.

[0346]

[0347] Synthesis of Dye 7

[0348] In a 100 mL single-necked reactor, intermediate 7-1 (3.0 g, 6.6 mmol), intermediate 7-2 (2.8 g, 6.6 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 7 (1.5 g).

[0349] The obtained Dye 7 1 H-NMR is as follows.

[0350] 1 H-NMR (400 MHz, DMSO-d6) δ 8.73 (t, 1H, J = 12.8 Hz), 8.36-8.28 (m, 2H), 8.00 (t, 1H, J = 7.6 Hz), 7.80 Hz), 8.21 (d, 1H, J = 8.0 Hz), 7.74-7.37 (m, 6H), 6.86 (d, 2H, J = 13.6 Hz), 4.03 (q, 2H, J = 7.6 Hz), 3.85 (s, 3H), 3.80 (s, 3H), 2.53 (m, 2), 2.10-1.75 (m, 9H) 1.19 (t, 3H,J = 8.0 Hz), 1.02-0.95 (m, 1H), 0.69-0.64 (m, 1H)

[0351]

[0352] Synthesis of Dye 8

[0353]

[0354]

[0355] Synthesis of intermediate 8-1

[0356] Intermediate 8-1 was synthesized with reference to US10473666, 2019, B2.

[0357]

[0358] Synthesis of intermediate 8-2

[0359] Intermediate 8-1 (10 g, 40.8 mmol), iodomethane (8.68 g, 61.2 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (100 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 8-2.

[0360]

[0361] Synthesis of intermediate 8-3

[0362] Intermediate 8-2 (3.0 g, 7.7 mmol), intermediate 7-1 (3.5 g, 7.7 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize intermediate 8-3.

[0363]

[0364] Synthesis of Dye 8

[0365] Intermediate 8-3 (2.0 g, 3.5 mmol), 2N aqueous sodium hydroxide solution (5 mL), and methanol (2 mL) were added to a 100 mL single-necked reactor and stirred at room temperature for 24 h. After concentration, 2M aqueous hydrochloric acid solution (10 mL) and dichloromethane (50 mL) were added and stirred. After separation of the organic layer, column purification was performed to synthesize Dye 8. (0.8 g)

[0366] The obtained Dye 8 1 H-NMR is as follows.

[0367] 1H-NMR (400 MHz, DMSO-d6) δ 8.73 (t, 1H, J = 12.8 Hz), 8.36-8.28 (m, 2H), 8.00 (t, 1H, J = 7.6 Hz), 7.80 (d, 1H, J = 8.0 Hz), 7.74-7.37 (m, 5H), 6.86 (d, 2H, J = 13.6 Hz), 3.96 (s, 2H), 3.85 (s, 3H), 3.80 (s, 3H), 2.12(s, 6H)

[0368]

[0369] Synthesis of Dye 9

[0370]

[0371]

[0372] Synthesis of intermediate 9-1

[0373] Intermediate 9-1 was synthesized with reference to US2011 / 152538, 2011, A1.

[0374]

[0375] Synthesis of intermediate 9-2

[0376] In a 250 mL three-necked reactor, intermediate 9-1 (10 g, 38 mmol) and tetrahydrofuran (100 mL) were added and stirred under a nitrogen flow at -78°C for 5 minutes. 1.6 M butyllithium (24 mL, 38 mmol) was added and stirred for 1 hour. Dry ice (5 g) was added and stirred at room temperature for 1 hour. After concentration, column purification was performed to synthesize intermediate 9-2.

[0377]

[0378] Synthesis of intermediate 9-3

[0379] Intermediate 9-2 (6 g, 23 mmol), iodoethyl (3.9 g, 25 mmol), potassium carbonate (9.0 g, 34 mmol), and N,N-dimethylformamide (60 mL) were added to a 250 mL single-necked reactor and stirred at room temperature for 24 hours. The solid was filtered and concentrated. Intermediate 9-3 was synthesized by column purification.

[0380]

[0381] Synthesis of intermediate 9-4

[0382] Intermediate 9-4 was synthesized with reference to Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647-2663.

[0383]

[0384] Synthesis of Dye 9

[0385] Intermediate 9-4 (1.0 g, 2.6 mmol), intermediate 4-1 (1.2 g, 2.6 mmol), and pyridine (10 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 9 (0.7 g).

[0386] The obtained Dye 9 1 H-NMR is as follows.

[0387] 1 H-NMR (400 MHz, DMSO-d6) δ 8.72 (t, 1H, J = 12.8 Hz), 8.50 (d, 1H, J = 8.0 Hz), 8.34 (d, 1H, J = 8.0 Hz), 8.18 (d, 1H, J = 8.4 Hz), 7.69 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.4 Hz), 7.57-7.50 (m, 2H), 7.45-7.10 (m, 2H), 6.98 (d, 1H, J = 13.6 Hz), 6.86 (d, 1H, J = 12.8 Hz), 3.97 (s, 3H), 3.85 (s, 3H), 2.13 (s, 6H)

[0388]

[0389] Synthesis of Dye 10

[0390]

[0391]

[0392] Synthesis of intermediate 10-1

[0393] Intermediate 10-1 was synthesized with reference to Chemical Communications, 2016, vol. 52, # 90, p. 13307 - 13310.

[0394]

[0395] Synthesis of intermediate 10-2

[0396] In a 250 mL three-necked reactor, add intermediate 10-1 (4.75 g, 18.2 mmol), 4-(ethoxycarbonyl)phenylboronic acid (5.0 g, 27.8 mmol), potassium carbonate (5.0 g, 36.4 mmol), Pd(PPh3)4 (0.1 g, 0.09 mmol), 1,2-dimethoxyethane (30 mL), water (9 mL), and N,N-dimethylformamide (65 mL) and stir at 85°C for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 10-2.

[0397]

[0398] Synthesis of intermediate 10-3

[0399] Intermediate 10-3 was synthesized with reference to Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0400]

[0401] Synthesis of Dye 10

[0402] Intermediate 10-3 (2.0 g, 4.5 mmol), intermediate 4-1 (2.0 g, 4.5 mmol), and pyridine (20 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 10 (1.1 g).

[0403] The obtained Dye 10 1 H-NMR is as follows.

[0404] 1 H-NMR (400 MHz, DMSO-d6) δ 8.75 (t, 1H, J = 12.8 Hz), 8.49 (d, 1H, J = 8.0 Hz), 8.33 (d, 1H, J = 8.0 Hz), 8.16 (d, 1H, J = 8.4 Hz), 8.14 (d, 2H, J = 8.7 Hz), 7.67 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.4 Hz), 7.60-7.49 (m, 2H), 7.47-7.12 (m, 4H), 7.00 (d, 1H, J = 13.6 Hz), 6.88 (d, 1H, J = 12.8 Hz), 3.96 (s, 3H), 3.84 (s, 3H), 2.11 (s, 6H)

[0405]

[0406] Synthesis of Dye 11

[0407]

[0408]

[0409] Synthesis of intermediate 11-1

[0410] Intermediate 11-1 was synthesized with reference to US9150922, 2015, B2.

[0411]

[0412] Synthesis of Dye 11

[0413] Dye 11 was synthesized using intermediates 11-1 and 6-2 with reference to the method of US9150922, 2015, B2.

[0414] The obtained Dye 11 1 H-NMR is as follows.

[0415] 1 H-NMR (400 MHz, DMSO-d6) δ 8.49-8.37 (m, 3H), 8.33 (d, 1H, J = 7.4 Hz), 8.21-8.00 (m, 2H), 7.67 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.4 Hz), 7.53-7.26 (m, 6H), 7.00 (d, 1H, J = 13.6 Hz), 6.85 (m, 2H), 4.22 (s, 3H), 3.85 (s, 3H), 2.11 (s, 6H)

[0416]

[0417] Synthesis of Dye 12

[0418]

[0419]

[0420] Synthesis of intermediate 12-1

[0421] Intermediate 12-1 was synthesized with reference to US2002 / 77487, 2002, A1.

[0422]

[0423] Synthesis of Dye 12

[0424] Intermediate 12-1 (2.0 g, 5.0 mmol), intermediate 7-1 (2.26 g, 5.0 mmol), and pyridine (20 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 12 (0.9 g).

[0425] The obtained Dye 12 1 H-NMR is as follows.

[0426] 1H-NMR (400 MHz, DMSO-d6) δ 8.87 (m, 2H), 8.53-8.33 (m, 3H), 8.20 (d, 1H, J = 7.2 Hz), 7.67 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.4 Hz), 7.42-7.26 (m, 2H), 6.85 (m, 2H), 4.52 (q, 2H, J = 7.2 Hz), 3.85 (s, 3H), 2.52 (m, 2H), 2.11 (s, 6H), 2.07-1.71 (m, 6H)

[0427]

[0428] Synthesis of Dye 13

[0429]

[0430]

[0431] Synthesis of intermediate 13-1

[0432] Intermediate 13-1 was synthesized with reference to Journal of Organic Chemistry, 2018, vol. 83, # 8, p. 4389 - 4401.

[0433]

[0434] Synthesis of intermediate 13-2

[0435] In a 1 L 4-necked reactor, add intermediate 13-1 (50 g, 0.202 mol), ethyl 4-piperidinecarboxylate (38 g, 0.242 mol), Pd2(dba)3 (7.4 g, 0.008 mol), BINAP (5.0 g, 0.008 mol), sodium tert-butoxide (27 g, 0.282 mol), and toluene (500 mL), and stir under reflux for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 13-2.

[0436]

[0437] Synthesis of intermediate 13-3

[0438] Intermediate 13-3 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0439]

[0440] Synthesis of Dye 13

[0441] Intermediate 13-3 (0.7 g, 1.6 mmol), intermediate 4-1 (0.72 g, 1.6 mmol), and pyridine (15 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 13. (0.3 g)

[0442] The obtained Dye 13 1 H-NMR is as follows.

[0443] 1 H-NMR (400 MHz, DMSO-d6) δ 8.75 (t, 1H, J = 12.6 Hz), 8.49 (d, 1H, J = 8.0 Hz), 8.31 (d, 1H, J = 8.28 (d, 1H, J = 8.4 Hz), 7.73-7.63 (m, 2H), 7.57-7.52 (m, 2H), 7.45-7.15 (m, 2H), 6.99 (d, 1H, J = 13.6 Hz), 6.88 (d, 1H, J = 12.8 Hz), 3.95 (s, 3H), 3.81 (s, 3H), 3.44 (m, 4H), 2.49-2.44 (m, 1H), 2.10 (s, 6H), 1.88-1.61 (m, 4H)

[0444]

[0445] Synthesis of Dye 14

[0446]

[0447]

[0448] Synthesis of intermediate 14-1

[0449] In a 500 mL single-necked reactor, add 3-nitro-9H-carbazole (20 g, 94 mmol), ethyl 4-bromobutyrate (22 g, 113 mmol), potassium carbonate (26 g, 190 mmol), and N,N-dimethylformamide (200 mL) and stir at 50°C for 12 hours. After concentration, add dichloromethane (200 mL) and water (100 mL), stir for 5 minutes, and separate the organic layer. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 14-1.

[0450]

[0451] Synthesis of intermediate 14-2

[0452] Intermediate 14-1 (12 g, 36 mmol), 5% Pd / C (0.6 g), and methane (120 mL) were added to a 500 mL single-necked reactor and stirred under a hydrogen stream for 24 hours. After filtering through Celite, the filtrate was concentrated to synthesize intermediate 14-2.

[0453]

[0454] Synthesis of intermediate 14-3

[0455] Intermediate 14-2 was synthesized into Intermediate 14-3 by referring to the method of KR2020 / 67733, 2020, A.

[0456]

[0457] Synthesis of Dye 14

[0458] Intermediate 14-3 (1.6 g, 3.2 mmol), intermediate 7-1 (1.4 g, 3.2 mmol), and pyridine (15 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 14. (0.7 g)

[0459] The obtained Dye 14 1 H-NMR is as follows.

[0460] 1H-NMR (400 MHz, DMSO-d6) δ 8.72 (t, 1H, J = 12.8 Hz), 8.52 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 7.2 Hz), 7.86-7.62 (m, 7H), 7.46-7.40 (m, 2H), 7.00 (d, 1H, J = 13.6 Hz), 6.83 (d, 1H, J = 12.8 Hz), 4.43 (t, 2H, J = 7.6 Hz), 4.12 (q, 2H, J = 7.6 Hz), 3.95 (s, 3H), 3.82 (s, 3H), 2.25 (t, 2H, J = 7.2 Hz), ), 2.12 (s, 6H), 1.91-1.87 (m, 2H), 1.33 (t, 3H, J = 7.6 Hz)

[0461]

[0462] Synthesis of Dye 15

[0463]

[0464]

[0465] Synthesis of intermediate 15-1

[0466] Intermediate 15-1 was synthesized with reference to Journal of the American Chemical Society, 2011, vol. 133, # 1, p. 51 - 55.

[0467]

[0468] Synthesis of Dye 15

[0469] Intermediate 15-1 (2.0 g, 3.5 mmol), intermediate 6-2 (1.1 g, 3.5 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 15 (0.9 g).

[0470] The obtained Dye 15 1H-NMR is as follows.

[0471] 1 H-NMR (400 MHz, DMSO-d6) δ 8.54 (d, 1H, J = 8.0 Hz), 8.49 (t, 2H, J = 15.6 Hz), 8.32 (d, 1H, J = 7.6 Hz), 8.31 (d, 1H, J = 8.2 Hz), 8.00 (t, 1H, J = 7.0 Hz), 7.72 (d, 1H, J = 8.4 Hz), 7.61 (t, 1H, J = 8.4 Hz), 7.60-7.50 (m, 2H), 7.44-7.14 (m, 2H), 6.87 (t, 1H, J = 13.6 Hz), 6.36 (d, 2H, J = 13.6 Hz), 4.23 (t, 2H, J = 7.2 Hz), 3.83 (s, 3H), 2.23 (m, 2H), 2.12 (s, 6H), 2.10-1.76 (m, 6H)

[0472]

[0473] Synthesis of Dye 16

[0474]

[0475]

[0476] Synthesis of intermediate 16-1

[0477] Intermediate 16-1 was synthesized with reference to CN113336743, 2021, A.

[0478]

[0479] Synthesis of Dye 16

[0480] Intermediate 16-1 (3.0 g, 6.6 mmol), intermediate 7-1 (3.0 g, 6.6 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 16. (2.1 g)

[0481] The obtained Dye 16 1 H-NMR is as follows.

[0482] 1 H-NMR (400 MHz, DMSO-d6) δ 8.89 (t, 1H, J = 12.6 Hz), 8.23-8.00 (m, 5H), 7.89 (t, 1H, J = 7.2 Hz), 7.77-7.47 (m, 7H), 7.19 (d, 1H, J = 7.2 Hz), 4.51 (t, 2H, J = 8.4 Hz), 3.97 (s, 3H), 2.54 (t, 2H, J = 6.8 Hz), 2.12 (s, 6H), 2.03-1.77 (m, 6H)

[0483]

[0484] Synthesis of Dye 17

[0485]

[0486]

[0487] Synthesis of intermediate 17-1

[0488] Intermediate 17-1 was synthesized with reference to US2020 / 0224257 A1.

[0489]

[0490] Synthesis of Dye 17

[0491] Intermediate 17-1 (3.0 g, 5.8 mmol), intermediate 7-1 (2.6 g, 5.8 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 17. (1.7 g)

[0492] The obtained Dye 17 1 H-NMR is as follows.

[0493] 1H-NMR (400 MHz, DMSO-d6) δ 8.75 (t, 1H, J = 12.8 Hz), 8.49 (d, 1H, J = 7.8 Hz), 8.44 (d, 1H, J = 7.6 Hz), 8182 (d, 1H, J = 8.2 Hz), 8.01 (t, 1H, J = 7.6 Hz), 7.86-7.40 (m, 8H), 6.68 (m, 2H), 4.58 (q, 2H, J = 6.8 Hz), 4.44 (t, 2H, J = 7.2 Hz), 4.21 (q, 2H, J = 7.8 Hz), 3.52 (s, 3H), 2.25 (t, 2H, J = 7.2 Hz), 2.11 (s, 6H), 1.93 (m, 2H), 1.32 (t, 3H, J = 7.8 Hz)

[0494]

[0495] Synthesis of Dye 18

[0496]

[0497]

[0498] Synthesis of intermediate 18-1

[0499] Intermediate 18-1 was synthesized with reference to Dyes and Pigments, 2022, vol. 197, art. no. 109874.

[0500]

[0501] Synthesis of intermediate 18-2

[0502] Intermediate 18-1 (10 g, 3.1 mmol), malonaldehyde dianilide hydrochloride (8.8 g, 34 mmol), and acetic anhydride (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 1 hour. After cooling, ethyl acetate (100 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 18-2.

[0503]

[0504] Synthesis of intermediate 18-3

[0505] Intermediate 18-3 was synthesized with reference to US2022 / 274960, 2022, A1.

[0506]

[0507] Synthesis of Dye 18

[0508] Intermediate 18-2 (1.9 g, 3.9 mmol), intermediate 18-3 (2.0 g, 3.9 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 18 (0.7 g).

[0509] The obtained Dye 18 1 H-NMR is as follows.

[0510] 1 H-NMR (400 MHz, DMSO-d6) δ 8.54 (d, 1H, J = 8.0 Hz), 8.49 (m, 2H), 8.32 (d, 1H, J = 8.0 Hz), 8.00 (t, 1H, J = 7.0 Hz), 7.81-7-40 (m, 9H), 6.87 (t, 1H, J = 13.6 Hz), 6.52 (d, 1H, J = 12.8 Hz) 6.36 (d, 1H, J = 13.6 Hz), 4.58 (q, 2H, J = 6.8 Hz), 4.23 (t, 2H, J = 7.2 Hz), 2.25 (t, 2H, J = 7.2 Hz), 1.93-1.75 (s, 9H), 1.56 (s, 6H), 1.35 (t, 3H, J = 7.2 Hz)

[0511]

[0512] Synthesis of Dye 19

[0513]

[0514]

[0515] Synthesis of intermediate 19-1

[0516] Intermediate 19-1 was synthesized with reference to KR2020 / 67732, 2020, A.

[0517]

[0518] Synthesis of intermediate 19-2

[0519] Intermediate 19-1 (10 g, 30 mmol), 6-bromohexanoic acid (8.9 g, 46 mmol), and 1,2-dichlorobenzene (100 mL) were added to a 250 mL single-necked reactor and stirred at 150°C for 2 hours. After cooling, acetone (100 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 19-2.

[0520]

[0521] Synthesis of Dye 19

[0522] In a 100 mL single-necked reactor, intermediate 19-2 (2.0 g, 3.8 mmol), intermediate 18-2 (1.9 g, 3.8 mmol), and pyridine (20 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 19. (0.3 g)

[0523] The obtained Dye 19 1 H-NMR is as follows.

[0524] 1H-NMR (400 MHz, DMSO-d6) δ 8.48-8.51 (m, 3H), 8.40 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 7.6 Hz), 7.86-7.40 (m, 6H), 7.19 (t, 1H, J = 8.0 Hz), 7.09 (t, 1H, 8.4 Hz), 6.75-6.53 (m, 3H), 4.41 (t, 2H, J = 7.2 Hz), 4.23 (q, 2H, J = 6.8 Hz), 3.91 (s, 3H), 2.53 (t, 2H, J = 7.2 Hz), 2.13 (s, 6H), 1.90-1.50 (m, 9H), 1.33 (t, 3H, J = 7.8 Hz)

[0525]

[0526] Synthesis of Dye 20

[0527]

[0528]

[0529] Synthesis of intermediate 20-1

[0530] Intermediate 20-1 was synthesized with reference to WO2017146187 A1.

[0531]

[0532] Synthesis of intermediate 20-2

[0533] Intermediate 20-1 (10 g, 35 mmol), 6-bromohexanoic acid (10.3 g, 53 mmol), and 1,2-dichlorobenzene (100 mL) were added to a 250 mL single-necked reactor and stirred at 150°C for 2 hours. After cooling, acetone (100 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 20-2.

[0534]

[0535] Synthesis of Dye 20

[0536] In a 100 mL single-necked reactor, intermediate 20-2 (3.0 g, 6.3 mmol), intermediate 7-1 (2.9 g, 6.3 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 20 (2.3 g).

[0537] The obtained Dye 20 1 H-NMR is as follows.

[0538] 1 H-NMR (400 MHz, DMSO-d6) δ 8.59-8.52 (m, 4H), 8.38 (d, 1H, J = 8.0 Hz), 8.30 (d, 1H), 8.22 (d, 1H, J = 8.2 Hz), 8.14-8.10 (m, 2H), 8.03 (t, 1H, J = 7.2 Hz), 7.90-7.65 (m, 3H), 7.53-7.42 (m, 2H), 6.83 (m, 2H), 4.28 (t, 2H, J = 6.8 Hz), 3.83 (s, 3H), 2.52 (t, 2H, J = 7.6 Hz), 2.10 (s, 6H), 1.98-1.53 ​​(m, 6H), 1.30 (t, 3H, J = 7.6 Hz)

[0539]

[0540] Synthesis of Dye 21

[0541]

[0542]

[0543] Synthesis of Dye 21

[0544] Intermediate 1-2 (2.0 g, 4.9 mmol), intermediate 7-1 (2.2 g, 4.9 mmol), and pyridine (10 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 21 (1.7 g).

[0545] The obtained Dye 21 1 H-NMR is as follows.

[0546] 1H-NMR (400 MHz, DMSO-d6) δ 9.14 (t, 1H, J = 12.8 Hz), 8.64 (d, 2H, J = 7.2 Hz), 8.33 (d, 2H, J = 7.6 Hz), 8.06-8.01 (m, 2H), 7.85 (d, 2H, J) = 7.0 Hz), 7.70-7.67 (m, 4H), 7.17 (d, 2H, J = 13.2 Hz), 4.33 (t, 2H, J =7.2 Hz), 3.92 (s, 3H), 2.51 (t, 2H, J = 7.6 Hz), 1.92-1.43 (m, 6H)

[0547]

[0548] Synthesis of Dye 22

[0549]

[0550]

[0551]

[0552] Synthesis of intermediate 22-1

[0553] Intermediate 22-1 was synthesized with reference to Organic Letters, 2019, vol. 21, # 14, p. 5694 - 5698.

[0554]

[0555] Synthesis of intermediate 22-2

[0556] Intermediate 22-2 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0557]

[0558] Synthesis of Dye 22

[0559] In a 100 mL single-necked reactor, intermediate 22-2 (1.3 g, 3.7 mmol), intermediate 6-1 (2.0 g, 3.7 mmol), and pyridine (13 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 22 (0.6 g).

[0560] The obtained Dye 22 1 H-NMR is as follows.

[0561] 1 H-NMR (400 MHz, DMSO-d6) δ 8.54 (t, 1H, J = 12.8 Hz), 8.37 (d, 1H, J = 7.8 Hz) 8.30 (d, 1H, J = 8.2 Hz), 8.04 (t, 1H, J = 7.2 Hz), 7.70-7.50 (m, 5H), 7.45-7.10 (m, 4H), 7.00 (d, 1H, J = 13.6 Hz), 6.88 (d, 1H, J = 12.8 Hz), 4.28 (t, 2H, J = 7.2 Hz), 3.84 (s, 3H), 2.51 (m, 2H), 2.13 (s, 6H), 2.09-1.75 (m, 6H)

[0562]

[0563] Synthesis of Dye 23

[0564]

[0565]

[0566] Synthesis of intermediate 23-1

[0567] Intermediate 23-1 was synthesized with reference to EP3882242, 2021, A1

[0568]

[0569] Synthesis of intermediate 23-2

[0570] Intermediate 23-2 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0571]

[0572] Synthesis of Dye 23

[0573] In a 100 mL single-necked reactor, intermediate 23-2 (3.2 g, 9.0 mmol), intermediate 6-1 (4.9 g, 9.0 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 23 (1.9 g).

[0574] The obtained Dye 23 1 H-NMR is as follows.

[0575] 1 H-NMR (400 MHz, DMSO-d6) δ 9.07 (d, 1H, J = 8.4 Hz), 8.72 (t, 1H, J = 12.8 Hz), 8.62 (d, 1H, J = 8.0 Hz), 8.41 (d, 1H, J = 7.8 Hz), 8.18 (d, 1H, J = 8.4 Hz), 7.62 (t, 1H, J = 8.4 Hz), 7.64-7.50 (m, 2H), 7.48-7.28 (m, 2H), 6.98 (d, 1H, J = 12.8 Hz), 6.84 (d, 1H, J = 12.8 Hz), 4.24 (t, 2H, J = 7.6 Hz), 3.97 (s, 3H), 2.52 (m, 2H), 2.10 (s, 6H), 2.11-1.73 (m, 6H)

[0576]

[0577] Synthesis of Dye 24

[0578]

[0579]

[0580] Synthesis of intermediate 24-1

[0581] Intermediate 9-1 was synthesized into Intermediate 24-1 by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0582]

[0583] Synthesis of Dye 24

[0584] Intermediate 24-1 (2.6 g, 6.7 mmol), intermediate 6-1 (3.7 g, 6.7 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 24 (1.9 g).

[0585] The obtained Dye 24 1 H-NMR is as follows.

[0586] 1 H-NMR (400 MHz, DMSO-d6) δ 8.70 (t, 1H, J = 12.8 Hz), 8.58 (d, 1H, J = 8.0 Hz), 8.39 (d, 1H, J = 7.2 Hz), 8.24 (d, 1H, J = 8.0 Hz), 7.89 (d, 1H, J = 8.4 Hz), 7.62 (t, 1H, J = 8.4 Hz), 7.59-7.28 (m, 4H), 6.82 (d, 1H, J = 12.8 Hz), 6.51 (d, 1H, J = 12.6 Hz), 4.22 (t, 2H, J = 7.8 Hz), 3.83 (s, 3H), 2.51 (m, 2H), 2.13 (s, 6H), 2.10-1.59 (m, 6H)

[0587]

[0588] Synthesis of Dye 25

[0589]

[0590]

[0591] Synthesis of intermediate 25-1

[0592] Intermediate 25-1 was synthesized with reference to the method of Journal of Organic Chemistry USSR 1982, vol. 18, # 2, p. 380 - 386.

[0593]

[0594] Synthesis of Dye 25

[0595] Intermediate 25-1 (2.0 g, 5.7 mmol), intermediate 6-1 (3.1 g, 5.7 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 25 (0.8 g).

[0596] The obtained Dye 25 1 H-NMR is as follows.

[0597] 1 H-NMR (400 MHz, DMSO-d6) δ 8.64 (t, 1H, J = 13.6 Hz), 8.55 (d, 1H, J = 8.0 Hz), 8.34 (d, 1H, J = 7.6 Hz), 8.22 (d, 1H, J = 7.8 Hz), 7.86 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.4 Hz), 7.53-7.22 (m, 4H), 6.80 (d, 1H, J = 12.8 Hz), 6.50 (d, 1H, J = 12.6 Hz), 4.22 (t, 2H, J = 7.6 Hz), 4.15 (q, 2H, J = 7.8 Hz), 3.90 (s, 3H), 2.51 (m, 2H), 2.11 (s, 6H), 2.11-1.50 (m, 6H), 1.32 (t, 3H, J = 7.2 Hz)

[0598]

[0599] Synthesis of Dye 26

[0600]

[0601]

[0602] Synthesis of intermediate 26-1

[0603] In a 500 mL 4-necked reactor, add intermediate 9-1 (20 g, 0.077 mol), N-methylaniline (9.8 g, 0.092 mol), Pd2(dba)3 (2.8 g, 0.003 mol), BINAP (1.9 g, 0.003 mol), sodium tert-butoxide (10.3 g, 0.107 mol), and toluene (200 mL) and stir under reflux for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 26-1.

[0604]

[0605] Synthesis of intermediate 26-2

[0606] Intermediate 26-2 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0607]

[0608] Synthesis of Dye 26

[0609] In a 100 mL single-necked reactor, intermediate 26-2 (3.0 g, 7.2 mmol), intermediate 6-1 (4.0 g, 7.2 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 26 (1.9 g).

[0610] The obtained Dye 26 1 H-NMR is as follows.

[0611] 1H-NMR (400 MHz, DMSO-d6) δ 8.63 (t, 1H, J = 13.6 Hz), 8.52 (d, 1H, J = 7.8 Hz), 8.32 (d, 1H, J = 7.8 Hz), 8.21 (d, 1H, J = 7.8 Hz), 7.84 (d, 1H, J = 8.2 Hz), 7.67 (t, 1H, J = 8.2 Hz), 7.58-7.22 (m, 9H), 6.96 (d, 1H, J = 12.6 Hz), 6.69 (d, 1H, J = 13.2 Hz), 4.22 (t, 2H, J = 7.6) Hz), 3.84 (s, 3H), 3.42 (s, 3H), 2.53 (m, 2H), 2.12 (s, 6H), 2.10-1.47 (m, 6H)

[0612]

[0613] Synthesis of Dye 27

[0614]

[0615]

[0616] Synthesis of intermediate 27-1

[0617] In a 500 mL 4-necked reactor, add intermediate 9-1 (20 g, 0.077 mol), piperidine (7.8 g, 0.092 mol), Pd2(dba)3 (2.8 g, 0.003 mol), BINAP (1.9 g, 0.003 mol), sodium tert-butoxide (10.3 g, 0.107 mol), and toluene (200 mL) and stir under reflux for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 27-1.

[0618]

[0619] Synthesis of intermediate 27-2

[0620] Intermediate 27-2 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0621]

[0622] Synthesis of Dye 27

[0623] In a 100 mL single-necked reactor, intermediate 27-2 (3.0 g, 7.6 mmol), intermediate 6-1 (4.2 g, 7.2 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 27 (1.6 g).

[0624] The obtained Dye 27 1 H-NMR is as follows.

[0625] 1 H-NMR (400 MHz, DMSO-d6) δ 8.67 (t, 1H, J = 13.6 Hz), 8.56 (d, 1H, J = 7.6 Hz), 8.37 (d, 1H, J = 8.0 Hz), 8.24 (d, 1H, J = 7.6 Hz), 7.84 (d, 1H, J = 8.0 Hz), 7.67 (m, 1H), 7.55-7.20 (m, 4H), 6.87 (d, 1H, J = 12.6 Hz), 6.70 (d, 1H, J = 12.6 Hz), 4.24 (t, 2H, J = 7.6 Hz), 3.84 (s, 3H), 3.40-3.34 (m, 4H), 2.53 (m, 2H), 2.12 (s, 6H), 2.10-1.47 (m, 12H)

[0626]

[0627] Synthesis of Dye 28

[0628]

[0629]

[0630] Synthesis of intermediate 28-1

[0631] In a 100 mL single-necked reactor, add Dye 6 (2 g, 3.4 mmol), 2-(methylamino)ethanol (0.3 g, 4.1 mmol), HATU (1.9 g, 5.1 mmol), triethylamine (1.4 mL, 10.1 mmol), and dimethylformamide (20 mL). Stir at room temperature for 1 hour. After concentration, add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 28-1.

[0632]

[0633] Synthesis of Dye 28

[0634] In a 25 mL single-necked reactor, add intermediate 28-1 (1.8 g, 2.8 mmol), 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite (0.85 g, 3.6 mmol), triethylamine (0.77 mL, 5.5 mmol), and dichloromethane (20 mL). Stir at room temperature for 1 hour. Add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize Dye 28. (1.5 g)

[0635] The obtained Dye 28 1 H-NMR is as follows.

[0636] 1H-NMR (400 MHz, DMSO-d6) δ 8.75 (t, 1H, J = 12.6 Hz), 8.50 (d, 1H, J = 8.0 Hz), 8.35 (d, 1H, J = 8.0 Hz), 8.21 (d, 1H, J = 8.2 Hz), 8.03 (t, 1H, J = 7.2 Hz), 7.70 (d, 1H, J = 8.4 Hz), 7.60 (t, 1H, J = 8.2 Hz), 7.60-7.50 (m, 2H), 7.44-7.12 (m, 2H), 6.97 (d, 1H, J = 13.6 Hz), 6.84 (d, 1H, J = 12.8 Hz), 4.25 (t, 2H, J = 7.4 Hz), 3.83 (s, 3H), 3.50-3.42 (m, 11H), 2.69 (t, 2H, J = 5.6 Hz), 2.48 (m, 2H), 2.13 (s, 6H), 2.10-1.75 (m, 6H), 1.20-1.18 (m, 12H)

[0637]

[0638] Synthesis of Dye 29

[0639]

[0640]

[0641] Synthesis of intermediate 29-1

[0642] In a 100 mL single-necked reactor, add Dye 6 (3.0 g, 5.1 mmol), 4-piperidinemethanol (0.70 g, 6.1 mmol), HATU (2.9 g, 7.6 mmol), triethylamine (2.1 mL, 15.2 mmol), and dimethylformamide (30 mL), and stir at room temperature for 1 hour. After concentration, add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 29-1.

[0643]

[0644] Synthesis of Dye 29

[0645] In a 25 mL single-necked reactor, add intermediate 29-1 (2.6 g, 3.8 mmol), 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite (1.2 g, 4.9 mmol), triethylamine (1 mL, 7.5 mmol), and dichloromethane (25 mL). Stir at room temperature for 1 hour. Add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize Dye 29. (2.2 g)

[0646] The obtained Dye 29 1 H-NMR is as follows.

[0647] 1 H-NMR (400 MHz, DMSO-d6) δ 8.77 (t, 1H, J = 12.8 Hz), 8.50 (d, 1H, J = 7.8 Hz), 8.33 (d, 1H, J = 7.8 Hz), 8.27 (d, 1H, J = 7.3 Hz), 8.03 (t, 1H, J = 7.8 Hz), 7.70 (d, 1H, J = 7.8 Hz), 7.63 (t, 1H, J = 8.2 Hz), 7.61-7.45 (m, 2H), 7.45-7.10 (m, 2H), 6.94 (d, 1H, J = 12.8 Hz), 6.84 (d, 1H, J = 12.8 Hz), 4.25 (t, 2H, J = 7.4 Hz), 3.83 (s, 3H), 3.70-3.48 (m, 10H), 2.78 (t, 2H, J = 5.8 Hz), 2.50 (m, 2H), 2.11 (s, 6H), 1.89-1.44 (m, 11H), 1.21-1.11 (m, 12H)

[0648]

[0649] Synthesis of Dye 30

[0650]

[0651]

[0652] Synthesis of intermediate 30-1

[0653] Intermediate 30-1 was synthesized with reference to Journal of the American Chemical Society 2004, vol. 126, # 27, p. 8364 - 8365.

[0654]

[0655] Synthesis of intermediate 30-2

[0656] In a 100 mL single-necked reactor, add Dye 6 (3.0 g, 5.1 mmol), intermediate 30-1 (2.47 g, 6.1 mmol), HATU (2.9 g, 7.6 mmol), triethylamine (2.1 mL, 15.2 mmol), and dimethylformamide (30 mL), and stir at room temperature for 1 hour. After concentration, add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 30-2.

[0657]

[0658] Synthesis of Dye 30

[0659] In a 25 mL single-necked reactor, add intermediate 30-2 (2.4 g, 2.0 mmol), 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite (0.62 g, 4.9 mmol), triethylamine (0.6 mL, 4.1 mmol), and dichloromethane (25 mL). Stir at room temperature for 1 hour. Add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize Dye 30. (1.1 g)

[0660] The obtained Dye 30 1 H-NMR is as follows.

[0661] 1H-NMR (400 MHz, DMSO-d6) δ 8.76 (t, 1H, J = 12.8 Hz), 8.52 (d, 1H, J = 7.8 Hz), 8.34 (d, 1H, J = 7.8 Hz), 8.28 (d, 1H, J = 7.4 Hz), 8.01 (t, 1H, J = 7.2 Hz), 7.71-7.63 (m, 2H), 7.61-7.45 (m, 2H), 7.45-7.10 (m, 11H), 6.94 (d, 1H, J = 12.8 Hz), 6.85-6.82 (m, 5H), 4.24 (t, 2H, J = 7.4 Hz), 3.84 (s, 3H), 3.77 (s, 6H), 3.59-3.41 (m, 12H), 2.76 (t, 2H, J = 6.2 Hz), 2.51 (m, 2H), 2.11 (s, 6H), 1.86-1.44 (m, 6H), 1.23-1.14 (m, 12H)

[0662]

[0663] Synthesis of Dye 31

[0664]

[0665]

[0666] Synthesis of intermediate 31-1

[0667] Intermediate 31-1 was synthesized with reference to US2020 / 369703, 2020, A1.

[0668]

[0669] Synthesis of intermediate 31-2

[0670] In a 100 mL single-necked reactor, add Dye 6 (4.0 g, 6.8 mmol), intermediate 31-1 (3.2 g, 8.1 mmol), HATU (3.9 g, 10.1 mmol), triethylamine (2.8 mL, 20.3 mmol), and dimethylformamide (40 mL) and stir at room temperature for 1 hour. After concentration, add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 31-2.

[0671]

[0672] Synthesis of Dye 31

[0673] In a 25 mL single-necked reactor, add intermediate 31-2 (2.5 g, 2.6 mmol), 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite (0.8 g, 3.4 mmol), triethylamine (0.7 mL, 5.2 mmol), and dichloromethane (25 mL). Stir at room temperature for 1 hour. Add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize Dye 31. (1.3 g)

[0674] The obtained Dye 31 1 H-NMR is as follows.

[0675] 1H-NMR (400 MHz, DMSO-d6) δ 8.77 (t, 1H, J = 12.8 Hz), 8.50 (d, 1H, J = 7.6 Hz), 8.36 (d, 1H, J = 8.0 Hz), 8.25 (d, 1H, J = 7.2 Hz), 8.00 (t, 1H, J = 7.2 Hz), 7.72-7.61 (m, 2H), 7.59-7.45 (m, 2H), 7.44-7.10 (m, 11H), 6.97 (d, 1H, J = 13.2 Hz), 6.87-6.80 (m, 5H), 4.22 (t, 2H, J = 7.4 Hz), 3.83 (s, 3H), 3.75 (s, 6H), 3.55-3.40 (m, 8H), 2.76 (t, 2H, J = 6.0 Hz), 2.50 (m, 2H), 2.13 (s, 6H), 1.90-1.40 (m, 6H), 1.21-1.11 (m, 12H)

[0676]

[0677] Synthesis of Dye 32

[0678]

[0679]

[0680] Synthesis of intermediate 32-1

[0681] Intermediate 32-1 was synthesized with reference to Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 1, p. 26 - 32.

[0682]

[0683] Synthesis of intermediate 32-2

[0684] In a 100 mL single-necked reactor, add Dye 6 (4.0 g, 6.8 mmol), intermediate 32-1 (3.4 g, 8.1 mmol), HATU (3.9 g, 10.1 mmol), triethylamine (2.8 mL, 20.3 mmol), and dimethylformamide (40 mL). Stir at room temperature for 1 hour. After concentration, add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 32-2.

[0685]

[0686] Synthesis of Dye 32

[0687] In a 25 mL single-necked reactor, add intermediate 32-2 (2.7 g, 2.7 mmol), 2-cyanoethyl N, N'-diisopropylchlorophosphoramidite (0.84 g, 3.5 mmol), triethylamine (0.8 mL, 5.4 mmol), and dichloromethane (30 mL). Stir at room temperature for 1 hour. Add water to the reactor, stir vigorously, and extract with dichloromethane. Add anhydrous sodium sulfate, stir for 5 minutes, and filter. The filtrate was concentrated and purified by column chromatography to synthesize Dye 32. (1.7 g)

[0688] The obtained Dye 32 1 H-NMR is as follows.

[0689] 1H-NMR (400 MHz, DMSO-d6) δ 8.77 (m, 1H), 8.49 (d, 1H, J = 7.6 Hz), 8.35 (d, 1H, J = 7.8 Hz), 8.27 (d, 1H, J = 7.6 Hz), 7.98 (t, 1H, J = 7.6) Hz), 7.70-7.45 (m, 4H), 7.44-7.09 (m, 11H), 6.95 (d, 1H, J = 13.2 Hz), 6.89-6.80 (m, 5H), 4.56 (m,1H), 4.22 (t, 2H, J = 7.4 Hz), 3.85 (s, 3H), 3.74 (s, 6H), 3.55-3.32 (m, 10H), 2.76 (t, 2H, J = 6.0 Hz), 2.50 (m, 2H), 2.13 (s, 6H), 1.90-1.40 (m, 8H), 1.21-1.11 (m, 12H)

[0690]

[0691] Synthesis of Dye 33

[0692]

[0693]

[0694] Synthesis of intermediate 33-1

[0695] Intermediate 33-1 was synthesized with reference to KR2016 / 90242, 2016, A.

[0696]

[0697] Synthesis of intermediate 33-2

[0698] Intermediate 33-2 was synthesized by referring to the method of Angew. Chem. Int. Ed. 2009, 48, 4222-4225.

[0699]

[0700] Synthesis of intermediate 33-3

[0701] Intermediate 33-3 was synthesized with reference to Organic Letters, 2001, vol. 3, # 16, p. 2591 - 2594.

[0702]

[0703] Synthesis of intermediate 33-4

[0704] Intermediate 33-2 (12 g, 50.2 mmol), intermediate 33-3 (17.2 g, 75.3 mmol), and acetonitrile (120 mL) were added to a 250 mL single-necked reactor and stirred at room temperature under reflux for 12 hours. After concentration, column purification was performed to synthesize intermediate 33-4.

[0705]

[0706] Synthesis of intermediate 33-5

[0707] In a 500 mL single-necked reactor, add intermediate 33-4 (18.0 g, 39 mmol), N,N-diphenylformamidine (8.3 g, 42 mmol), and acetic anhydride (200 mL) and stir at 110°C for 1 hour. After cooling, pour the reaction solution into ethyl acetate (500 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 33-5.

[0708]

[0709] Synthesis of Dye 33

[0710] In a 100 mL single-necked reactor, intermediate 33-5 (3.0 g, 4.9 mmol), intermediate 23-2 (1.7 g, 4.9 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, 6N aqueous hydrochloric acid solution (20 mL) was added and stirred at room temperature for 12 hours. After concentration, column purification was performed to synthesize Dye 33. (1.6 g)

[0711] The obtained Dye 33 1 H-NMR is as follows.

[0712] 1H-NMR (400 MHz, DMSO-d6) δ 9.08 (d, 1H, J = 8.2 Hz), 8.71 (t, 1H, J = 12.6 Hz), 8.61 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.18 (d, 1H, J = 8.4 Hz), 7.88-7.40 (m, 7H), 6.97 (d, 1H, J = 12.6 Hz), 6.83 (d, 1H, J = 12.6 Hz), 4.25 (t, 2H, J = 7.6 Hz), 3.86 (m, 2H), 3.97 (s, 3H), 2.09 (m, 2H)

[0713]

[0714] Synthesis of Dye 34

[0715]

[0716]

[0717] Synthesis of intermediate 34-1

[0718] Intermediate 34-1 was synthesized with reference to Chemistry of Heterocyclic Compounds, 1988, vol. 24, p. 87 - 92.

[0719]

[0720] Synthesis of intermediate 34-2

[0721] Intermediate 34-1 (10 g, 37.7 mmol), intermediate 33-3 (12.9 g, 56.6 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred at room temperature under reflux for 12 hours. After concentration, column purification was performed to synthesize intermediate 34-2.

[0722]

[0723] Synthesis of intermediate 34-3

[0724] In a 250 mL single-necked reactor, add intermediate 34-3 (15.0 g, 30 mmol), N,N-diphenylformamidine (6.6 g, 33 mmol), and acetic anhydride (150 mL) and stir at 110°C for 1 hour. After cooling, pour the reaction solution into ethyl acetate (500 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 34-3.

[0725]

[0726] Synthesis of Dye 34

[0727] In a 100 mL single-necked reactor, intermediate 33-5 (3.0 g, 4.7 mmol), intermediate 25-1 (1.7 g, 4.7 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, 6 N aqueous hydrochloric acid solution (20 mL) was added and stirred at room temperature for 12 hours. After concentration, column purification was performed to synthesize Dye 34. (1.8 g)

[0728] The obtained Dye 34 1 H-NMR is as follows.

[0729] 1 H-NMR (400 MHz, DMSO-d6) δ 8.62 (t, 1H, J = 12.8 Hz), 8.60 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.23-8.01 (m, 2H) 7.93-7.40 (m, 8H), 6.67 (m, 2H), 4.25 (t, 2H, J = 7.6 Hz), 4.22 (q, 2H, J = 7.2 Hz), 3.86 (m, 2H), 2.09 (m, 2H), 1.18 (t, 2H, J = 7.2 Hz)

[0730]

[0731] Synthesis of Dye 36

[0732]

[0733]

[0734] Synthesis of intermediate 36-1

[0735] Intermediate 36-1 was synthesized with reference to CN115304539, 2022, A.

[0736]

[0737] Synthesis of intermediate 36-2

[0738] Intermediate 36-1 (10 g, 25 mmol), malonaldehyde dianilide hydrochloride (7.1 g, 27 mmol), and acetic anhydride (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 1 hour. After cooling, ethyl acetate (500 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 36-2.

[0739]

[0740] Synthesis of intermediate 36-3

[0741] 4-Bromobutyric acid was synthesized as intermediate 36-3 by referring to the method of US2022 / 274960, 2022, A1.

[0742]

[0743] Synthesis of intermediate 36-4

[0744] Intermediate 36-2 (4.0 g, 7.0 mmol), intermediate 36-3 (3.1 g, 7.0 mmol), and pyridine (40 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize intermediate 36-4.

[0745]

[0746] Synthesis of Dye 36

[0747] In a 100 mL single-necked reactor, intermediate 36-4 (2.0 g, 2.8 mmol), HSTU (O-(N-Succinimidyl)-N,N,N',N'-tetramethyl uronium hexafluoro phosphate) (1.6 g, 3.6 mmol), triethylamine (1.2 mL, 8.3 mmol), and dimethylformamide (20 mL) were added and stirred at room temperature for 30 minutes. After concentration, column purification was performed to synthesize Dye 36. (1.7 g)

[0748] The obtained Dye 36 1 H-NMR is as follows.

[0749] 1 H-NMR (400 MHz, DMSO-d6) δ 8.70 (t, 1H, J = 12.8 Hz), 8.54 (d, 1H, J = 8.0 Hz), 8.38 (d, 1H, J = 7.8 Hz), 8.23-7.40 (m, 10H), 6.76 (m, 2H), 4.25 (t, 2H, J = 7.2 Hz), 4.22 (q, 2H, J = 7.2 Hz), 2.85 (s, 4H), 2.50 (t, 2H, J = 7.6 Hz), 2.09 (m, 2H), 1.76 (s, 6H), 1.73 (s, 6H) 1.21 (t, 2H, J = 7.2 Hz)

[0750]

[0751] Synthesis of Dye 38

[0752]

[0753]

[0754] Synthesis of intermediate 38-1

[0755] Intermediate 38-1 was synthesized with reference to KR2015 / 130206, 2015 A1.

[0756]

[0757] Synthesis of intermediate 38-2

[0758] In a 2 L 4-necked reactor, intermediate 38-1 (70 g, 0.256 mol), benzophenolhydrazine (60 g, 0.229 mol), Pd2(dba)3 (9.4 g, 0.010 mol), BINAP (6.4 g, 0.010 mmol), sodium-tert-butoxide (35 g, 0.359 mol), and toluene (700 mL) were added and stirred at 100°C for 12 hours. The solid was filtered while hot through a Celite layer. After concentration, the mixture was purified by column chromatography to synthesize intermediate 38-2.

[0759]

[0760] Synthesis of intermediate 38-3

[0761] In a 1 L, 1-neck reactor, intermediate 38-2 (80 g, 0.206 mol), 7-methyl-8-oxo-nonanoic acid (57.6 g, 0.309 mol), concentrated hydrochloric acid (160 mL), and ethanol (640 mL) were added and stirred under reflux for 12 hours. After concentration, water (500 mL) was added to the reactor and extracted with ethyl acetate (500 mL x 2). Anhydrous magnesium sulfate was added to the organic layer, stirred for 5 minutes, and the solid was filtered. After concentration, column purification was performed to synthesize intermediate 38-3.

[0762]

[0763] Synthesis of intermediate 38-4

[0764] Intermediate 38-3 (10 g, 24.8 mmol), iodomethane (5.3 g, 37.2 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (200 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 38-4.

[0765]

[0766] Synthesis of intermediate 38-5

[0767] Intermediate 27-2 (8 g, 20 mmol), malonaldehyde dianilide hydrochloride (5.8 g, 22 mmol), and acetic anhydride (80 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 1 hour. After cooling, ethyl acetate (300 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 38-5.

[0768]

[0769] Synthesis of Dye 38

[0770] In a 100 mL single-necked reactor, intermediate 38-4 (2.0 g, 3.7 mmol), intermediate 38-5 (2.1 g, 3.7 mmol), and pyridine (20 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 38. (0.7 g)

[0771] The obtained Dye 38 1 H-NMR is as follows.

[0772] 1 H-NMR (400 MHz, DMSO-d6) δ 8.52-8.50 (m, 3H), 8.38 (d, 1H, J = 7.8 Hz), 8.20-7.22 (m, 9H), 6.87 (t, 1H, J = 12.6 Hz), 6.35 (d, 2H, J = 13.6 Hz), 3.98 (s, 3H), 3.80 (s, 3H), 3.44-3.40 (m, 4H), 2.54 (t, 2H, J = 7.6 Hz), 2.10-1.75 (m, 21H), 1.02-0.95 (m, 1H), 0.69-0.64 (m, 1H)

[0773]

[0774] Synthesis of Dye 41

[0775]

[0776]

[0777] Synthesis of intermediate 41-1

[0778] 2-Methylnaphthyl[1,2,-d]oxazole (10 g, 54.6 mmol), iodomethane (11.6 g, 81.9 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux at room temperature for 12 hours. After concentration, column purification was performed to synthesize intermediate 41-1.

[0779]

[0780] Synthesis of intermediate 41-2

[0781] In a 500 mL single-necked reactor, add intermediate 41-1 (12.0 g, 37 mmol), N,N-diphenylformamidine (8.0 g, 41 mmol), and acetic anhydride (120 mL) and stir at 110°C for 1 hour. After cooling, pour the reaction solution into ethyl acetate (600 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 41-2.

[0782]

[0783] Synthesis of Dye 41

[0784] Intermediate 41-2 (4.0 g, 8.5 mmol), intermediate 1-2 (3.5 g, 8.5 mmol), and pyridine (40 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 41. (1.4 g)

[0785] The obtained Dye 41 1 H-NMR is as follows.

[0786] 1H-NMR (400 MHz, DMSO-d6) δ 8.60 (t, 1H, J = 12.6 Hz), 8.51 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.20-8.18 (m, 3H), 7.93-7.90 (m, 3H), 7.62-7.34 (m, 4H), 6.97 (d, 1H, J = 12.6 Hz), 6.83 (d, 1H, J = 12.6 Hz), 4.25 (t, 2H, J = 7.6 Hz), 3.87 (s, 3H), 2.54 (m, 2H), 2.08-1.73 (m, 6H)

[0787]

[0788] Synthesis of Dye 42

[0789]

[0790]

[0791] Synthesis of intermediate 42-1

[0792] Intermediate 42-1 was synthesized with reference to US2020 / 0224257 A1.

[0793]

[0794] Synthesis of Dye 42

[0795] In a 100 mL single-necked reactor, intermediate 42-1 (3.0 g, 5.8 mmol), intermediate 7-1 (2.6 g, 5.8 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 42 (1.7 g).

[0796] The obtained Dye 42 1 H-NMR is as follows.

[0797] 1H-NMR (400 MHz, DMSO-d6) δ 8.70 (t, 1H, J = 13.2 Hz), 8.52 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 7.6 Hz), 7.86-7.40 (m, 8H), 7.00 (d, 1H, J = 14.0 Hz), 6.81 (d, 1H, J = 12.8 Hz), 4.58 (q, 2H, J = 6.8 Hz), 4.44 (t, 2H, J = 7.2 Hz), 3.76 (s, 3H), 2.25 (t, 2H, J = 7..2 Hz), 2.11 (s, 6H), 1.93-1.50 (m, 6H), 1.35 (t, 3H, J = 7.2 Hz)

[0798]

[0799] Synthesis of Dye 43

[0800]

[0801]

[0802] Synthesis of intermediate 43-1

[0803] Intermediate 43-1 was synthesized with reference to KR2015 / 130206, 2015 A1.

[0804]

[0805] Synthesis of intermediate 43-2

[0806] Intermediate 43-2 was synthesized with reference to the synthesis methods of intermediates 38-2 and 38-3.

[0807]

[0808] Synthesis of intermediate 43-3

[0809] Intermediate 43-2 (10 g, 38.1 mmol), iodoethane (8.9 g, 57.2 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (200 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 43-3.

[0810]

[0811] Synthesis of intermediate 43-4

[0812] In a 250 mL single-necked reactor, add intermediate 43-3 (6.0 g, 14 mmol), N,N-diphenylformamidine (3.1 g, 16 mmol), and acetic anhydride (60 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (200 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 43-4.

[0813]

[0814] Synthesis of Dye 43

[0815] In a 100 mL single-necked reactor, intermediate 43-4 (3.0 g, 5.3 mmol), intermediate 9-4 (1.9 g, 5.3 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 43. (0.4 g)

[0816] The obtained Dye 43 1 H-NMR is as follows.

[0817] 1H-NMR (400 MHz, DMSO-d6) δ 9.03 (d, 1H, J = 8.0 Hz), 8.70 (t, 1H, J = 12.6 Hz), 8.51 (d, 1H, J = 8.0 Hz), 8.22 (d, 1H, J = 8.4 Hz), 7.98 (m, 1H), 7.86-7.40 (m, 7H), 7.00 (d, 1H, J = 14.0 Hz), 6.81 (d, 1H, J = 12.6 Hz), 4.55 (q, 2H, J = 7.2 Hz), 3.87 (s, 3H), 3.76 (s, 3H), 2.10 (s, 6H), 1.35 (t, 3H, J = 7.2 Hz)

[0818]

[0819] Synthesis of Dye 47

[0820]

[0821]

[0822] Synthesis of intermediate 47-1

[0823] Intermediate 47-1 was synthesized with reference to KR2015 / 130206, 2015 A1.

[0824]

[0825] Synthesis of intermediate 47-2

[0826] Intermediate 47-2 was synthesized with reference to the synthetic methods of Intermediate 38-2 and Intermediate 38-3.

[0827]

[0828] Synthesis of intermediate 47-3

[0829] In a 250 mL single-necked reactor, add intermediate 47-2 (10 g, 30 mmol), iodomethane (6.4 g, 45 mmol), and acetonitrile (100 mL) and stir under reflux for 24 hours. After cooling, add ethyl acetate (100 mL) and stir for 10 minutes. The resulting solid was filtered to synthesize intermediate 47-3.

[0830]

[0831] Synthesis of intermediate 47-4

[0832] Intermediate 47-4 was synthesized with reference to US2022 / 59772, 2022, A1.

[0833]

[0834] Synthesis of intermediate 47-5

[0835] Intermediate 47-5 was synthesized by referring to the method of Bioconjugate Chemistry 2019, vol. 30, # 10, p. 2647 - 2663.

[0836]

[0837] Synthesis of intermediate 47-6

[0838] In a 250 mL single-necked reactor, add intermediate 47-5 (5.0 g, 13 mmol), N,N-diphenylformamidine (2.8 g, 14 mmol), and acetic anhydride (50 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 47-6.

[0839]

[0840] Synthesis of Dye 47

[0841] Intermediate 47-3 (2.7 g, 5.7 mmol), intermediate 47-6 (3.0 g, 5.7 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 47. (1.1 g)

[0842] The obtained Dye 47 1 H-NMR is as follows.

[0843] 1H-NMR (400 MHz, DMSO-d6) δ 8.54 (t, 1H, J = 12.6 Hz), 8.49 (d, 1H, J = 8.0 Hz), 8.38 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.0 Hz), 8.02 (d, 1H, J = 7.8 Hz), 7.84-7.38 (m, 13H), 6.81 (m, 2H), 5.87 (s, 2H), 3.97 (s, 3H), 3.86 (m, 2H), 3.80 (s, 3H), 2.10-1.75 (m, 11H), 1.02-0.95 (m, 1H), 0.69-0.64 (m, 1H)

[0844]

[0845] Synthesis of Dye 48

[0846]

[0847]

[0848] Synthesis of intermediate 48-1

[0849] Intermediate 34-1 was synthesized into Intermediate 48-1 by referring to the method of US2020 / 0224257 A1.

[0850]

[0851] Synthesis of Dye 48

[0852] Intermediate 48-1 (2.0 g, 3.9 mmol), intermediate 7-1 (1.8 g, 3.9 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 48 (0.3 g).

[0853] The obtained Dye 48 1 H-NMR is as follows.

[0854] 1H-NMR (400 MHz, DMSO-d6) δ 8.62 (t, 1H, J = 12.8 Hz), 8.60 (d, 1H, J = 8.0 Hz), 8.40 (d, 1H, J = 7.8 Hz), 8.23-8.01 (m, 2H) 7.93-7.40 (m, 9H), 6.67 (m, 2H), 4.20 (t, 2H, J = 7.6 Hz), 3.77 (s, 3H), 2.66 (t, 2H, J = 7.6 Hz), 2.11 (s, 6H), 1.92-1.67 (m, 6H)

[0855]

[0856] Synthesis of Dye 55

[0857]

[0858]

[0859] Synthesis of intermediate 55-1

[0860] Intermediate 55-1 was synthesized with reference to IN202241025324.

[0861]

[0862] Synthesis of intermediate 55-2

[0863] Intermediate 55-2 was synthesized by referring to the method of Angew. Chem. Int. Ed.2009, 48, 4222-4225.

[0864]

[0865] Synthesis of intermediate 55-3

[0866] Intermediate 55-2 (10 g, 32 mmol), iodoethane (7.4 g, 48 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (100 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 55-3.

[0867]

[0868] Synthesis of intermediate 55-4

[0869] In a 250 mL single-necked reactor, add intermediate 55-3 (5.0 g, 11 mmol), N,N-diphenylformamidine (2.3 g, 12 mmol), and acetic anhydride (50 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 55-4.

[0870]

[0871] Synthesis of Dye 55

[0872] In a 100 mL single-necked reactor, intermediate 55-4 (2.0 g, 3.2 mmol), intermediate 1-2 (1.3 g, 3.2 mmol), and pyridine (20 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 55 (0.2 g).

[0873] The obtained Dye 55 1 H-NMR is as follows.

[0874] 1 H-NMR (400 MHz, DMSO-d6) δ 8.64 (t, 1H, J = 12.8 Hz), 8.54 (d, 1H, J = 8.0 Hz), 8.45-8.40 (m, 2H), 8.23-8.01 (m, 2H), 7.85-7.68 (m, 4H), 7.28-6.96 (m, 10H), 6.67 (m, 2H), 4.28 (q, 2H, J = 7.2 Hz), 4.20 (t, 2H, J = 7.6 Hz), 2.57 (t, 2H, J = 7.2 Hz), 1.98-1.69 (m, 6H), 1.49 (t, 3H, J = 7.2 Hz)

[0875]

[0876] Synthesis of Dye 57

[0877]

[0878]

[0879] Synthesis of intermediate 57-1

[0880] In a 250 mL single-necked reactor, add intermediate 20-1 (8.0 g, 28 mmol), iodopropane (7.2 g, 42 mmol), and acetonitrile (80 mL) and stir under reflux for 24 hours. After cooling, add ethyl acetate (100 mL) and stir for 10 minutes. The resulting solid was filtered to synthesize intermediate 57-1.

[0881]

[0882] Synthesis of intermediate 57-2

[0883] In a 250 mL single-necked reactor, add intermediate 57-1 (6.0 g, 13 mmol), N,N-diphenylformamidine (2.9 g, 15 mmol), and acetic anhydride (50 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 57-2.

[0884]

[0885] Synthesis of Dye 57

[0886] Intermediate 57-2 (3.0 g, 5.0 mmol), intermediate 9-4 (1.8 g, 5.0 mmol), and pyridine (30 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 57 (1.4 g).

[0887] The obtained Dye 57 1 H-NMR is as follows.

[0888] 1H-NMR (400 MHz, DMSO-d6) δ 9.03 (d, 1H, J = 8.0 Hz), 8.60-8.52 (m, 3H), 8.38 (d, 1H, J = 8.0 Hz), 8.31 (d, 1H), 8.22 (d, 1H, J = 8.0 Hz), 8.15-8.10 (m, 2H), 8.03 (t, 1H, J = 7.2 Hz), 7.90-7.62 (m, 2H), 7.54-7.40 (m, 2H), 6.83 (m, 2H), 4.28 (t, 2H, J = 7.2 Hz), 3.85 (s, 3H), 1.96 (m, 2H), 2.10 (s, 6H), 1.35 (t, 3H, J = 7.6 Hz)

[0889]

[0890] Synthesis of Dye 59

[0891]

[0892]

[0893] Synthesis of intermediate 59-1

[0894] Intermediate 59-1 was synthesized with reference to KR2020 / 67733, 2020, A.

[0895]

[0896] Synthesis of intermediate 59-2

[0897] Intermediate 59-2 was synthesized with reference to EP1221465, 2002, A1.

[0898]

[0899] Synthesis of Dye 59

[0900] In a 100 mL single-necked reactor, intermediate 59-1 (4.3 g, 10.0 mmol), intermediate 6-2 (3.0 g, 10.0 mmol), intermediate 59-2 (1.9 g, 5.0 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 59. (0.4 g)

[0901] The obtained Dye 59 1 H-NMR is as follows.

[0902] 1 H-NMR (400 MHz, DMSO-d6) δ 8.44 (d, 2H, J = 12.8 Hz), 8.49 (d, 1H, J = 8.0 Hz), 8.38 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.0 Hz), 8.02 (d, 1H, J = 7.8 Hz), 7.95-7.38 (m, 12H), 6.34 (d, 2H, J = 13.2 Hz), 4.26 (q, 2H, J = 7.8 Hz), 4.02 (q, 2H, J = 7.6 Hz), 3.80 (s, 3H), 2.10 (s, 6H), 1.37 (t, 3H, J = 7.6 Hz), 1.09 (t, 3H, J = 7.8 Hz)

[0903]

[0904] Synthesis of Dye 60

[0905]

[0906]

[0907] Synthesis of intermediate 60-1

[0908] Intermediate 60-1 was synthesized with reference to Journal of the Indian Chemical Society, 1968, vol. 45, p. 799 - 809.

[0909]

[0910] Synthesis of Dye 60

[0911] In a 100 mL single-necked reactor, intermediate 60-1 (2.0 g, 4.3 mmol), intermediate 1-2 (1.8 g, 4.3 mmol), and pyridine (20 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 60 (0.1 g).

[0912] The obtained Dye 60 1 H-NMR is as follows.

[0913] 1 H-NMR (400 MHz, DMSO-d6) δ 8.69 (t, 1H, J = 12.8 Hz), 8.50 (d, 1H, J = 7.2 Hz), 8.40 (d, 1H, J = 8.0 Hz), 8.20 (d, 1H, J = 8.2 Hz), 7.88 (t, 1H, J = 7.2 Hz), 7.75-7.53 (m, 4H), 7.47-7.25 (m, 3H), 7.00 (d, 1H, J = 7.0 Hz), 6.88 (d, 1H, J = 13.4 Hz), 6.52 (d, 1H, J = 13.2 Hz), 4.46 (q, 2H, J = 7.6 Hz), 3.97 (s, 3), 2.55 (m, 2H), 2.08-1.72 (m, 6H)

[0914]

[0915] Synthesis of Dye 61

[0916]

[0917]

[0918] Synthesis of intermediate 61-1

[0919] Intermediate 61-1 was synthesized with reference to US2166736, 1937, A.

[0920]

[0921] Synthesis of Dye 61

[0922] In a 100 mL single-necked reactor, intermediate 61-1 (4.0 g, 8.0 mmol), intermediate 1-2 (3.3 g, 8.0 mmol), and pyridine (40 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 61 (2.3 g).

[0923] The obtained Dye 61 1 H-NMR is as follows.

[0924] 1H-NMR (400 MHz, DMSO-d6) δ 8.73 (t, 1H, J = 13.4 Hz), 8.52 (d, 1H, J = 7.8 Hz), 8.42 (d, 1H, J = 8.2 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.00 (t, 1H, J = 7.2 Hz), 7.76-7.51 (m, 4H), 7.49-7.25 (m, 3H), 7.01 (d, 1H, J = 7.2 Hz), 6.88 (d, 1H, J = 12.8 Hz), 6.52 (d, 1H, J = 13.2 Hz), 4.51 (q, 2H, J = 7.6 Hz), 4.22 (t, 2H, J = 7.8 Hz), 2.57 (m, 2H), 2.10-1.74 (m, 6H), 1.33 (t, 3H, J = 7.8 Hz)

[0925]

[0926] Synthesis of Dye 62

[0927]

[0928]

[0929] Synthesis of intermediate 62-1

[0930] Intermediate 62-1 was synthesized with reference to the synthetic methods of Intermediate 38-2 and Intermediate 38-3.

[0931]

[0932] Synthesis of intermediate 62-2

[0933] Intermediate 62-1 (6 g, 17 mmol), iodomethane (3.7 g, 26 mmol), and acetonitrile (60 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (100 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 62-2.

[0934]

[0935] Synthesis of Dye 62

[0936] Intermediate 62-2 (2.0 g, 4.0 mmol), intermediate 7-1 (1.9 g, 48.0 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 62 (1.1 g).

[0937] The obtained Dye 62 1 H-NMR is as follows.

[0938] 1 H-NMR (400 MHz, DMSO-d6) δ 8.55 (t, 1H, J = 13.4 Hz), 8.43 (d, 1H, J = 7.80 Hz), 8.32 (d, 1H, J = 7.8 Hz), 8.20 (d, 1H, J = 8.0 Hz), 8.00 (d, 1H, J = 7.2 Hz), 7.86-7.39 (m, 8H), 6.82 (m, 2H), 5.87 (s, 2H), 4.16 (s, 3H), 3.86 (s, 3H), 3.82 (m 2H), 2.10-1.75 (m, 15H), 1.02-0.95 (m, 1H), 0.69-0.64 (m, 1H)

[0939]

[0940] Synthesis of Dye 63

[0941]

[0942]

[0943] Synthesis of intermediate 63-1

[0944] Intermediate 63-1 was synthesized with reference to Chemical Communications, 2016, vol. 52, # 90, p. 13307 - 13310.

[0945]

[0946] Synthesis of intermediate 63-2

[0947] In a 250 mL three-necked reactor, add intermediate 63-1 (4.75 g, 18.2 mmol), 4-(ethoxycarbonyl)phenylboronic acid (5.0 g, 27.8 mmol), potassium carbonate (5.0 g, 36.4 mmol), Pd(PPh3)4 (0.1 g, 0.09 mmol), 1,2-dimethoxyethane (30 mL), water (9 mL), and N,N-dimethylformamide (65 mL) and stir at 85°C for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 63-2.

[0948]

[0949] Synthesis of intermediate 63-3

[0950] Intermediate 63-3 was synthesized with reference to Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0951]

[0952] Synthesis of Dye 63

[0953] Intermediate 63-3 (3.0 g, 7.1 mmol), intermediate 43-4 (4.0 g, 7.1 mmol), and pyridine (20 mL) were added to a 50 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 63 (1.3 g).

[0954] The obtained Dye 63 1 H-NMR is as follows.

[0955] 1H-NMR (400 MHz, DMSO-d6) δ 8.63 (t, 1H, J = 12.8 Hz), 8.43 (d, 1H, J = 8.0 Hz), 8.37 (d, 1H, J = 7.8 Hz), 8.16 (d, 1H, J = 8.0 Hz), 8.14 (d, 2H, J = 8.0 Hz), 7.78-7.49 (m, 6H), 7.45-7.12 (m, 4H), 6.88 (d, 1H, J = 12.8 Hz), 6.54 (d, 1H, J = 13.4 Hz), 4.52 (q, 2H, J = 7.8 Hz), 3.83 (s, 3H), 3.76 (s, 3H), 2.11 (s, 6H), 1.35 (t, 3H, J = 7.8 Hz)

[0956]

[0957] Synthesis of Dye 66

[0958]

[0959]

[0960] Synthesis of intermediate 66-1

[0961] Intermediate 66-1 was synthesized with reference to Journal of Organic Chemistry, 2018, vol. 83, # 8, p. 4389 - 4401.

[0962]

[0963] Synthesis of intermediate 66-2

[0964] In a 1 L 4-necked reactor, add intermediate 66-1 (50 g, 0.202 mol), ethyl 4-piperidinecarboxylate (38 g, 0.242 mol), Pd2(dba)3 (7.4 g, 0.008 mol), BINAP (5.0 g, 0.008 mol), sodium tert-butoxide (27 g, 0.282 mol), and toluene (500 mL), and stir under reflux for 12 hours. After cooling, filter the solid through Celite. The filtrate was concentrated and purified by column chromatography to synthesize intermediate 66-2.

[0965]

[0966] Synthesis of intermediate 66-3

[0967] Intermediate 66-3 was synthesized by referring to the method of Bioconjugate Chemistry, 2019, vol. 30, # 10, p. 2647 - 2663.

[0968]

[0969] Synthesis of intermediate 66-4

[0970] Intermediate 66-4 was synthesized with reference to Chemistry of Heterocyclic Compounds, 1988, vol. 24, p. 87 - 92.

[0971]

[0972] Synthesis of intermediate 66-5

[0973] Intermediate 66-4 (10.0 g, 38 mmol), iodomethane (8.0 g, 57 mmol), and acetonitrile (100 mL) were added to a 250 mL single-necked reactor and stirred under reflux for 24 hours. After cooling, ethyl acetate (100 mL) was added and stirred for 10 minutes. The resulting solid was filtered to synthesize intermediate 66-5.

[0974]

[0975] Synthesis of intermediate 66-6

[0976] In a 250 mL single-necked reactor, add intermediate 66-5 (5.0 g, 12 mmol), N,N-diphenylformamidine (2.6 g, 14 mmol), and acetic anhydride (50 mL) and stir at 110°C for 1 hour. After cooling, add ethyl acetate (100 mL) and stir vigorously. The resulting solid was filtered to synthesize intermediate 75-6.

[0977]

[0978] Synthesis of Dye 66

[0979] In a 50 mL single-necked reactor, intermediate 66-3 (3.0 g, 6.9 mmol), intermediate 66-6 (3.8 g, 6.9 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, the mixture was purified by column to synthesize Dye 66 (0.9 g).

[0980] The obtained Dye 66 1 H-NMR is as follows.

[0981] 1 H-NMR (400 MHz, DMSO-d6) δ 8.54 (t, 1H, J = 12.6 Hz), 8.30 (d, 1H, J = 8.2 Hz), 8.03 (d, 1H, J = 8.4 Hz), 7.73-7.63 (m, 3H), 7.57-7.15 (m, 6H), 6.67 (d, 1H, J = 13.6 Hz), 6.51 (d, 1H, J = 12.8 Hz), 3.95 (s, 3H), 3.81 (s, 3H), 3.44 (m, 4H), 2.49-2.44 (m, 1H), 2.10 (s, 6H), 1.88-1.61 (m, 4H)

[0982]

[0983] Synthesis of Dye 77

[0984]

[0985]

[0986] Synthesis of intermediate 77-1

[0987] Intermediate 77-1 was synthesized with reference to KR2020 / 67732, 2020, A.

[0988]

[0989] Synthesis of intermediate 77-2

[0990] Intermediate 77-1 (10 g, 30 mmol), 6-bromohexanoic acid (8.9 g, 46 mmol), and 1,2-dichlorobenzene (100 mL) were added to a 250 mL single-necked reactor and stirred at 150°C for 2 hours. After cooling, acetone (100 mL) was added to the reactor and stirred for 5 minutes. The resulting solid was filtered to synthesize intermediate 77-2.

[0991]

[0992] Synthesis of Dye 77

[0993] Intermediate 77-2 (2.0 g, 3.8 mmol), intermediate 18-2 (1.9 g, 3.8 mmol), and pyridine (20 mL) were added to a 100 mL single-necked reactor and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 77 (0.7 g).

[0994] The obtained Dye 77 1 H-NMR is as follows.

[0995] 1 H-NMR (400 MHz, DMSO-d6) δ 8.48-8.51 (m, 3H), 8.40 (d, 1H, J = 7.8 Hz), 8.22 (d, 1H, J = 8.4 Hz), 8.03 (t, 1H, J = 7.6 Hz), 7.86-7.40 (m, 4H), 7.19 (t, 1H, J = 8.0 Hz), 7.09 (t, 1H, 8.4 Hz), 6.75-6.53 (m, 3H), 4.41 (t, 2H, J = 7.2 Hz), 4.23 (q, 2H, J = 6.8 Hz), 3.61 (s, 3H), 2.53 (t, 2H, J = 7.2 Hz), 2.13 (s, 6H), 1.90-1.50 (m, 12H), 1.33 (t, 3H, J = 7.8 Hz)

[0996]

[0997] Synthesis of Dye 82

[0998]

[0999]

[1000] Synthesis of intermediate 82-1

[1001] Intermediate 82-1 was synthesized with reference to Dyes and Pigments, 2014, vol. 101, p. 1 - 8.

[1002]

[1003] Synthesis of intermediate 82-2

[1004] Intermediate 82-2 was synthesized with reference to Journal of the American Chemical Society, 2011, vol. 133, # 40, p. 15870 - 15873.

[1005]

[1006] Synthesis of Dye 82

[1007] In a 100 mL single-necked reactor, intermediate 82-1 (4.7 g, 10.0 mmol), intermediate 6-2 (3.0 g, 10.0 mmol), intermediate 82-2 (1.6 g, 5.0 mmol), and pyridine (30 mL) were added and stirred at 50°C for 1 hour. After concentration, column purification was performed to synthesize Dye 82. (0.3 g)

[1008] The obtained Dye 82 1 H-NMR is as follows.

[1009] 1H-NMR (400 MHz, DMSO-d6) δ 8.54 (d, 2H, J = 13.4 Hz), 8.49 (m, 2H), 8.32 (d, 1H, J = 8.0 Hz), 8.02 (t, 1H, J = 7.2 Hz), 7.79-7.38 (m, 8H), 6.58 (d, 2H, J = 12.8 Hz), 4.39 (s, 3H), 3.76 (s, 3H), 2.82 (t, 2H, J = 7.8 Hz), 2.17 (t, 2H, J = 7.8 Hz), 2.07-1.99 (m, 4H), 1.73 (s, 6H), 0.89-0.67 (m, 10H)

[1010]

[1011] The photophysical properties measured in DMSO solvent for the non-fluorescent compounds synthesized according to the synthetic examples described above are as shown in Table 1 below.

[1012] Distinction λ abs (nm)e max Quantum Yield(Φ)Dye 266428,0000.006Dye 667275,0000.005Dye 1267653,0000.002Dye 1669268,0000.001Dye 1767237,0000.002Dye 1868074,0000.005Dye 4869065,0000.001Dye 6060042,0000.007Dye 6163024,0000.002

[1013]

[1014] Referring to Table 1 above, it can be expected that the non-fluorescent compound defined herein will exhibit a quenching effect on the luminescence properties of the fluorescent compound by the FRET mechanism in the wavelength range of about 550 to 900 nm.

[1015]

[1016] Experimental Example 1. Evaluation of pH-dependent spectral changes of a conjugate (oligonucleotide) with a single label at the 3'-terminal position of a non-fluorescent compound.

[1017] Among the non-fluorescent compounds synthesized according to the synthetic examples described above, conjugates were prepared in which Dye 2, Dye 16, and Dye 17 and commercially available quenchers BHQ1, BHQ2, and BHQ3 were labeled at the 3'-end of the oligonucleotide, respectively, and the spectral changes of the conjugates according to pH were confirmed.

[1018] Division sequence (5' → 3')Ex 1-15'-SEQ 1-Dye 2-3'Ex 1-25'-SEQ 1-Dye 16-3'Ex 1-35'-SEQ 1-Dye 17-3'Ex 1-45'-SEQ 1-BHQ1-3'Ex 1-55'-SEQ 1-BHQ2-3'Ex 1-65'-SEQ 1-BHQ3-3'

[1019] *SEQ 1: TTTTTTTTTT

[1020]

[1021] Specifically, the conjugate is MerMade using CPG (Controlled Pore Glass) substituted with a non-fluorescent compound as a support. TM It was synthesized with 10 thymines sequentially attached from the 3' position in a 48X DNA synthesizer (see Table 2).

[1022] Next, each non-fluorescent compound was dropped on the labeled T10 oligonucleotide on a stationary support in a standard manner (NH4OH, 30 v / v% in H2O), and then RP-HPLC was applied to separate only the full-length product (FLP) and dried.

[1023] The dried conjugates were titrated to pH 2, 5, 6, 8, and 10 using a pH meter, and all were diluted to 3 μM. The spectral changes of all solutions were measured at room temperature using a UV spectrophotometer.

[1024] Distinction λ max(nm) shift depending on pHpH 2pH 5pH 6pH 8pH 10Ex 1-1664664664664664Ex 1-2692692692692691Ex 1-3672672672672671Ex 1-4580548540540541Ex 1-5610588582583583Ex 1-6664671675681677

[1025]

[1026] Referring to Table 3 above, Ex 1-4 to Ex 1-6 show a large change in lamda max as the pH decreases, and the standard deviation changes in a large range of about 6 to 17 nm in the pH range of 2 to 10, whereas Ex 1-1 to Ex 1-3 all maintain a constant spectrum within the pH range of 2 to 10, indicating that the influence of pH is minimal, and the standard deviation is about 0 to 0.4, confirming that the characteristics of non-fluorescent compounds are maintained within a wide pH range.

[1027]

[1028] Experimental Example 2. Evaluation of quenching efficiency according to the distance between the quencher and the phosphor.

[1029] Forward probes (hereinafter referred to as 'fp') and reverse probes (hereinafter referred to as 'rp') were synthesized according to the methods shown in Table 4 below. The reverse probes shown in Table 4 have complementary sequences to all or part of the forward probe.

[1030] For reference, rp 1-1, rp 2-1, and rp 3-1 hybridize with fp1 and fp2, respectively, to form blunt ended hybrids; rp 1-2, rp 2-2, and rp 3-2 hybridize with fp1 and fp2, respectively, to form 5-mer staggered hybrids; and rp 1-3, rp 2-3, and rp 3-3 hybridize with fp1 and fp2, respectively, to form 10-mer staggered hybrids. Schematic diagrams of the blunt ended hybrid, 5-mer staggered hybrid, and 10-mer staggered hybrid are shown in Fig. 1. Here, the blunt ended hybrid is a hybrid for confirming static quenching, that is, the quenching phenomenon due to the formation of a ground state complex between the quencher and the fluorophore, and the staggered hybrid is a hybrid for confirming dynamic quenching, particularly the quenching phenomenon due to FRET.

[1031] The above forward probe and the above reverse probe were synthesized using the same method as described in Experimental Example 1.

[1032] Division sequence (5' → 3')fp 15'-6-FAM-SEQ 2-3'fp 25'-Cy5-SEQ 2-3'rp 1-15'-SEQ 3-Dye 2-3'rp 1-25'-SEQ 4-Dye 2-3'rp 1-35'-SEQ 5-Dye 2-3'rp 2-15'-SEQ 3-Dye 16-3'rp 2-25'-SEQ 4-Dye 16-3'rp 2-35'-SEQ 5-Dye 16-3'rp 3-15'-SEQ 3-Dye 17-3'rp 3-25'-SEQ 4-Dye 17-3'rp 3-35'-SEQ 5-Dye 17-3'

[1033] *SEQ 2: TTTTTTTTTTTAGCTTGCAGATGTCATAGT

[1034] *SEQ 3: ACTATGACATCTGCAAGCTAAAAAAAAAA

[1035] *SEQ 4: ACTATGACATCTGCAAGCTAAAAAA

[1036] *SEQ 5: ACTATGACATCTGCAAGCTA

[1037]

[1038] In order to evaluate the quenching efficiency according to the distance between the quencher and the fluorophore, first, the fluorescence amounts of fp 1 and fp2, which are conjugates in which only the fluorophore is labeled at the 5'-end, were each measured, and then the forward probe and the reverse probe were hybridized with the combinations shown in Table 5 below, and the fluorescence amounts were each measured, and the two measurement results were substituted into Equation 1 below to evaluate the quenching efficiency.

[1039] [Formula 1]

[1040]

[1041]

[1042] Fluorescent-labeled oligonucleotides were diluted to a concentration of 0.3 uM using hybridization buffer (final concentration: NaCl 50 mM, MgCl2 5 mM, Tris-HCl 10 mM) and fluorescence was measured using a Varioskan LUX Multimode microplate reader (Thermo Fisher Scientific) (6-FAM: λ ex 495 nm / λ em 520 nm, Cy5:λ ex 650 nm / λ em665 nm). Then, the fluorophore-labeled oligonucleotide and quencher-labeled oligonucleotide were diluted to 0.3 uM and 0.6 uM concentrations, respectively, with hybridization buffer, and the fluorescence amount according to the distance between the fluorophore and quencher was measured using a Varioskan LUX Multimode microplate reader.

[1043] Distinctive probe combination extinction efficiency (%) Forward probe Reverse probe Ex 2-1fp 1rp 1-192rp 1-287rp 1-377Ex 2-2rp 2-192rp 2-288rp 2-372Ex 2-3rp 3-192rp 3-288rp 3-375Ex 2-4fp 2rp 1-195rp 1-295rp 1-394Ex 2-5rp 2-190rp 2-290rp 2-387Ex 2-6rp 3-195rp 3-295rp 3-394

[1044]

[1045] Cy5, a commercially available fluorescent compound, is a representative RED region fluorophore with maximum emission at 650 nm, and Dye 2, Dye 16, and Dye 17 have maximum absorption above 650 nm, so a quenching phenomenon according to the FRET mechanism can occur due to the overlap of the emission-absorption spectra of the fluorophore and quencher. Referring to the results in Table 5, the difference in quenching efficiency according to the distance between the fluorophore and the quencher is only 1 to 3%, confirming that the non-fluorescent compound defined herein can exhibit quenching phenomenon not only through dynamic quenching represented by the FRET mechanism but also through static quenching. While 6-FAM, a commercially available fluorescent compound, is a representative short-wavelength fluorophore with maximum emission at 520 nm, Dye 2, Dye 16, and Dye 17 have maximum absorption at 650 nm or higher, so the overlap of the emission-absorption spectra of the fluorophore and the quencher is minimal.

[1046] Referring to the results in Table 5, the quenching efficiency decreases by 15-20% as the distance between the fluorophore and the quencher increases. It can be expected that the quenching phenomenon due to static quenching occurs as the fluorophore and quencher form a dimer through the interaction that occurs as the fluorophore and quencher get closer.

[1047]

[1048] Experimental Example 3. Evaluation of binding stability according to the combination of fluorescent material and quencher.

[1049] Forward probes (hereinafter referred to as 'fp') and reverse probes (hereinafter referred to as 'rp') were synthesized according to the methods shown in Table 6 below. The forward probes and reverse probes were synthesized using the same method as described in Experimental Example 1.

[1050] Division sequence (5' → 3')fp 45'-Cy5-SEQ 2-3'rp 4-15'-SEQ 3-3'rp 4-25'-SEQ 3-Dye 2-3'rp 4-35'-SEQ 3-Dye 16-3'rp 4-45'-SEQ 3-Dye 17-3'

[1051]

[1052] In order to evaluate the binding stability according to the combination of fluorophore and quencher, the forward probe and the reverse probe were hybridized with the combinations shown in Table 7 below, and then the temperature was increased from 37°C to 95°C in 0.5°C intervals, and Tm (melting temperature) was measured from the Melt Curve. The hybridization of the forward probe and the reverse probe was diluted to a concentration of 0.3 uM with hybridization buffer (final concentration: NaCl 50 mM, MgCl 25 mM, Tris-HCl 10 mM), and SYBR Green was adjusted to 1X to create a hybrid, and then Tm was measured using a CFX96 PCR machine (Biorad).

[1053] Distinctive probe combination Tm (℃) Forward probe Reverse probe Ex 3-1fp 4rp 4-170.4 Ex 3-1fp 4rp 4-272.5 Ex 3-2fp 4rp 4-372.8 Ex 3-3fp 4rp 4-473.3

[1054]

[1055] Referring to the results in Table 7, it can be confirmed that the Tm of the hybrid of the quencher-labeled oligonucleotide is increased by approximately 3°C compared to the hybrid of the oligonucleotide (Ex 3-1, 3-2) without the quencher. The above results are expected to be due to the fact that the binding force of the double-stranded oligonucleotide created by the affinity between the fluorophore and the quencher becomes more stable by using the non-fluorescent compound defined herein as the quencher.

[1056]

[1057] Experimental Example 4. Evaluation of the signal-to-noise ratio (S / N Ratio) of PCR using dual-labeled oligonucleotides

[1058] With reference to the above experimental examples, according to the combinations shown in Table 8 below, dual-labeled oligonucleotides were prepared in which the 5' end was labeled with a commercially available fluorescent compound, 6-FAM, HEX, TAMRA, Cy5, or Cy5.5, and the 3' end was labeled with a commercially available quencher, BHQ-1, BHQ-2, or BHQ-3, and the non-fluorescent compound, Dye 2, Dye 16, or Dye 17, defined herein, were labeled, and the PCR characteristics and signal-to-noise ratio (S / N ratio) were evaluated through PCR analysis (see Table 9) using the dual-labeled oligonucleotides. Real-Time PCR for BQCV (black queen cell virus) plasmid DNA was performed twice for 10 fg / ul of template (using Bio-Rad, CFX-96TM Touch). The evaluation results are shown in FIGS. 2 and 3 .

[1059] 구분서열(5' → 3')Ex 4-15'-6-FAM-SEQ 6-BHQ-1-3'End 4-25'-6-FAM-SEQ 6-Dye 2-1-3'Ex 4-35'-6-xFAM-1-SEQ 6 4-45'-6-FAM-SEQ 6-Dye 17-1-3'End 4-55'-HEX-SEQ 6-BHQ-1-3'End 4-65'-HEX-SEQ 6-Dye 2-1-3'End 4-75'-HEX-SEQ 1x-1Dye 4-85'-HEX-SEQ 6-Dye 17-1-3'E 4-95'-TAMRA-SEQ 6-BHQ-2-3'E 4-105'-TAMRA-SEQ 6-Dye 2-1-3'E 4-115'-TAMRA-1D-3-SEQ 6 4-125'-TAMRA-SEQ 6-Dye 17-1-3'Ex 4-135'-Cy5-SEQ 6-BHQ-2-3'End 4-145'-Cy5-SEQ 6-Dye 2-1-3'Ex 4-155'-E3-Cy5-ye 4-165'-Cy5-SEQ 6-Dye 17-1-3'Ex 4-175'-Cy5.5-SEQ 6-BHQ-3-3'End 4-185'-Cy5.5-SEQ 6-Dye 2-1-3'End 4-SEQy 6-195'-Cy 16-1-3'And 4-205'-Cy5.5-SEQ 6-Dye 17-1-3'

[1060] *SEQ 6: Black queen cell virus complement (23 mer; CCATCTTTATCGGTACGCCGCCC)

[1061] 구분함량(ul)(Violine) SensiFAST TM Probe No-ROX Mix (2X)10BQCV plasmid DNA (10 fg / ul)3BQCV F / R primer mix (5 pmole / ul)1BQCV Dual-labeled probe (5 pmole / ul)1DEPC Water5

[1062] * PCR Protocol: 95℃, 3min - [95℃, 10s - 60℃, 30s] x 45cycles

[1063]

[1064] Referring to FIGS. 2 and 3, it was confirmed that when the non-fluorescent compound defined herein was used as a quencher, a lower Ct value and a higher S / N ratio were obtained compared to when the commercially available quenchers BHQ-1, BHQ-2, or BHQ-3 were used for the commercially available fluorophores 6-FAM, HEX, TAMRA, Cy5, and Cy5.5.

[1065] Based on the above results, it was confirmed that the non-fluorescent compound defined herein can be used as a quencher for various fluorophores with different emission spectra, even as a single compound. Furthermore, considering the aspect of molecular diagnostics, it is expected that the detection ease and detection accuracy will be higher than those of commercially available quenchers, even when the target gene is present at a relatively low concentration in the sample. In particular, it was confirmed that the non-fluorescent compound defined herein can function as a molecular diagnostic probe through static quenching even when the wavelength overlap with 6-FAM is small.

[1066]

[1067] Experimental Example 5. Sequence Dependency Evaluation of Dual-Labeled Oligonucleotides

[1068] With reference to the above experimental examples, according to the combinations shown in Table 10 below, dual-labeled oligonucleotides were prepared in which the 5' end was labeled with Cy5, a commercially available fluorescent compound, and the 3' end was labeled with BHQ-2, a commercially available quencher, and Dye 6, Dye 18, or Dye 60, a non-fluorescent compound defined herein, were labeled, and PCR characteristics and signal-to-noise ratio (S / N ratio) were evaluated through PCR analysis (see Table 9) using the dual-labeled oligonucleotides. The evaluation results are shown in Table 11 and Figures 4 to 6.<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1069] <h2 style=";text-align:left;direction:ltr"> 구분서열(5' → 3')Ex 5-15'-Cy5-SEQ 7-Dye 6-3'Ex 5-25'-Cy5-SEQ 7-BHQ-2-3'Ex 5-35'-Cy5-SEQ 8-Dye 18-3'Ex 5-45'-Cy5-SEQ 8-BHQ-2-3'Ex 5-55'-Cy5-SEQ 9-Dye 60-3'Ex 5-65'-Cy5-SEQ 9-BHQ-2-3'<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1070] <h2 style=";text-align:left;direction:ltr"> *SEQ 7: Neisseria gonorrhoeae complement (23 mer; CAGTCGAGAACAGCAAAGCAACG)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1071] <h2 style=";text-align:left;direction:ltr"> *SEQ 8: Mycoplasma genitalium complement (28 mer; AGCCTTTCTAACCGCTGCACTTACCCTT)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1072] <h2 style=";text-align:left;direction:ltr"> *SEQ 9: Chlamydia trachomatis complement (27 mer; TTGTCCATATCTTTGATACGACGCCGC)<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1073] <h2 style=";text-align:left;direction:ltr"> 구분DNA (fg / ul)CtBackgroundS / N RatioNorm. S / N RatioEx 5-1100020.1341385.271.5510023.611026.83130.20Ex 5-2100020.1062413.391.0010023.601026.96130.32Ex 5-3100023.8826265.651.4510027.021030.37133.36Ex 5-4100024.1540673.901.0010027.141030.49133.59Ex 5-5100023.6747563.631.2410026.861030.14133.47Ex 5-6100023.9560952.941.0010027.121030.34133.88<h2 style=";text-align:left;direction:ltr"> <h2 style=";text-align:left;direction:ltr">

[1074] Referring to Table 11 and FIGS. 4 to 9, the range of Ct values ​​of the non-fluorescent compounds defined herein is -0.41 < ΔCt < 0.03, which confirms that they have a sensitivity equal to or higher than that of the commercialized quencher BHQ-2, and exhibit lower background and higher S / N ratio than the commercialized quencher.

[1075]

[1076] Experimental Example 6. Evaluation of Reducing Agent Resistance of Dual-Labeled Oligonucleotides

[1077] Referring to the above experimental examples, according to the combinations shown in Table 12 below, dual-labeled oligonucleotides were prepared in which the 5' end was labeled with a commercially available fluorescent compound, 6-FAM, Cy5, or Cy5.5, and the 3' end was labeled with a commercially available quencher, BHQ-1, BHQ-2, or BHQ-3, and the non-fluorescent compound, Dye 6, Dye 48, or Dye 60, defined herein, were labeled. 100 mM DTT (1,4-dithiothreitol) was added as a reducing agent, and the HPLC purity change was measured when the reaction was performed overnight for 24 hours. Specifically, the oligonucleotides according to dried Ex 6-1 to Ex 6-6 were quantified to 100 uM with a 100 mM DTT solution, and the purity was immediately measured. After storing them at room temperature (21°C) for 24 hours, the purity was measured using the same method. The evaluation results are shown in FIGS. 7 and 8.

[1078] Division sequence (5' → 3')Ex 6-15'-6-FAM-SEQ 10-Dye 6-3'Ex 6-25'-Cy5-SEQ 10-Dye 48-3'Ex 6-35'-Cy5.5-SEQ 10-Dye 60-3'Ex 6-45'-6-FAM-SEQ 10-BHQ 1-3'Ex 6-55'-Cy5-SEQ 10-BHQ 2-3'Ex 6-65'-Cy5.5-SEQ 10-BHQ 3-3'

[1079] *SEQ 10: TTTTTTTTTTTTTTTTTTTT

[1080]

[1081] Referring to FIGS. 7 and 8, it was confirmed that the oligonucleotides using the non-fluorescent compounds defined herein as quenchers showed a slight change in purity from a minimum of 0.4% to a maximum of 1.6% in the presence of a reducing agent, whereas the oligonucleotides using the commercially available quenchers BHQ-1, BHQ-2, or BHQ-3 as quenchers showed a rapid change in purity from a minimum of 69.7% to a maximum of 86.7% in the presence of a reducing agent. In other words, the non-fluorescent compounds defined herein can be maintained in a stable state even in the presence of a reducing agent due to their high durability, and thus are expected to be used in a wider variety of molecular diagnostic fields than the commercially available quenchers.

[1082]

[1083] Experimental Example 7. Comparison of the efficiency of dual-labeled oligonucleotides in the presence of MGB.

[1084] With reference to the above experimental examples, dual-labeled oligonucleotides were prepared in which the 5' end was labeled with a commercially available fluorescent compound, 6-FAM, HEX, TAMRA, or Cy5, and the 3' end was labeled with a non-fluorescent compound, Dye 12, Dye 48, or Dye 61, as defined herein, and a Minor Groove Binder (MGB) was included, according to the combinations shown in Table 13 below. The PCR characteristics (see Experimental Example 4) and Tm changes (see Experimental Example 3) according to the inclusion of a Minor Groove Binder (MGB) in the dual-labeled oligonucleotides were measured. The measurement results are shown in Table 14 and FIGS. 9 to 12.

[1085] Specifically, dual-labeled oligonucleotides containing MGB were MerMade using MGB-CPG with Dye 12, Dye 48 or Dye 61 substituted as support. TMIn a 48X DNA synthesizer, only the oxidation step was changed from the standard method that can give side reaction elements to MGB to 0.5 M CSO [(1S)-(+)-(10-camphorsulfonyl)-oxaziridine], and oligonucleotides were synthesized so that the complementary sequence (14 mer) to each target was attached as a probe in order from the 3' position. Then, 6-FAM, HEX, TAMRA, or Cy5 was attached to the 5' end, and the fluorescently labeled probe was separated from the stationary phase support by the standard method (NH4OH, 30 v / v% in H2O), and then only the FLP (Full-Length Product) was separated and dried by applying RP-HPLC.

[1086] Division sequence (5' → 3')Ex 7-15'-6-FAM-SEQ 11-MGB-Dye 61-3'Ex 7-25'-HEX-SEQ 11-MGB-Dye 61-3'Ex 7-35'-TAMRA-SEQ 11-MGB-Dye 12-3'Ex 7-45'-Cy5-SEQ 11-MGB-Dye 48-3'Ex 7-55'-6-FAM-SEQ 11-Dye 61-3'Ex 7-65'-HEX-SEQ 11-Dye 61-3'Ex 7-75'-TAMRA-SEQ 11-Dye 12-3'Ex 7-85'-Cy5-SEQ 11-Dye 48-3'

[1087] *SEQ 11: Black queen cell virus complement (14 mer; TTATCGGTACGCCG)

[1088] Category 6-FAMHEXTAMRACy5Ex 7-1 ~ Ex 7-464.4℃61.1℃60.5℃63.7℃Ex 7-5 ~ Ex 7-858.2℃55.3℃55.0℃57.6℃

[1089] Referring to Table 14, it can be confirmed that the average Tm value of Ex 7-1 to Ex 7-4 is approximately 6℃ higher than that of Ex 7-5 to Ex 7-8. In addition, referring to FIGS. 9 to 12, it can be confirmed that the ΔRFU of Ex 7-1 to Ex 7-4 increases and the Ct value decreases compared to that of Ex 7-5 to Ex 7-8.

[1090]

[1091] Experimental Example 8. Evaluation of PCR characteristics of oligonucleotides containing multiple quenchers.

[1092] Referring to the above experimental examples, according to the combinations shown in Table 15 below, a commercially available fluorescent compound, 6-FAM, is labeled at the 5' end, a commercially available quencher, IBFQ (Iowa Black FQ), a non-fluorescent compound, Dye 6, Dye 18 or Dye 60, as defined herein, is labeled at the 3' end, and a commercially available quencher, Eclipse, is placed between the oligonucleotides. ® (Elitech group.) or the PCR characteristics of oligonucleotides with added ZEN (see Experimental Example 4) were evaluated. Ex 8-5 was used as is, a triple-labeled oligonucleotide sold by Integrated DNA Technologies, Inc. The results of the evaluation are shown in Fig. 13.

[1093] Distinctive double / triple labeled probes (probe sequence: M. musculus complement) Ex 8-15'-6-FAM-SEQ 12-Dye 6 -3' Ex 8-25'-6-FAM-SEQ 12-Dye 18 -3' Ex 8-35'-6-FAM-SEQ 12-Dye 60 -3' Ex 8-45'-6-FAM-SEQ 13-Dye 6-3' Ex 8-55'-6-FAM-SEQ 14-IBFQ-3'

[1094] *SEQ 12: AAGAGTAGT-Eclipse-AGCCTAAGAGTGTCAGTTGTACATCA

[1095] *SEQ 13: AAGAGTAGTAGCCTAAGAGTGTCAGTTGTACATCA

[1096] *SEQ 14: AAGAGTAGT-ZEN-AGCCTAAGAGTGTCAGTTGTACATCA

[1097]

[1098] Referring to FIG. 13, it was confirmed that the background of the triple-labeled oligonucleotides containing two quenchers, Ex 8-1 to Ex 8-3, was reduced by 65%, ΔRFU increased by 42%, and had a lower Ct value compared to the double-labeled oligonucleotide, Ex 8-4, which is a double-labeled oligonucleotide containing a single quencher. In other words, it was confirmed that the PCR amplification performance of the triple-labeled oligonucleotide containing two quenchers was superior to that of the double-labeled oligonucleotide containing a single quencher.

[1099] In addition, it was confirmed that Ex 8-1 to Ex 8-3, which include non-fluorescent compounds defined herein among the two quenchers, exhibited PCR amplification performance similar to that of Ex 8-5, a commercially available triple-labeled oligonucleotide.

[1100]

[1101] Experimental Example 9. Solubility Evaluation of Non-Fluorescent Compounds

[1102] Referring to the synthesis method of Dye 6 among the synthesis examples, R4 and R in the structure of Dye 6 11 In the structure of this non-fluorescent compound and Dye 6, which is a hydroxyl group (-OH), R4 and R 11 This sulfonate (-SO3 - ) were additionally synthesized, and the solubility of the non-fluorescent compound in each solvent shown in Table 16 below was measured. Specifically, an amount corresponding to 2 mg of the non-fluorescent compound was added to 2 ml of the solvent, and the mixture was left at 25°C for 30 minutes, and then it was confirmed whether the non-fluorescent compound was completely dissolved.

[1103] Classification Ex 9-1 (Dye 6) Ex 9-2 (-OH modification) Ex 9-2 (-SO3 - Modified example) Dichloromethane OOX Acetonitrile OOX Methanol OOX Purified water XXO

[1104]

[1105] Referring to Table 16, it was confirmed that non-fluorescent compounds according to Ex 9-1 and Ex 9-2 were fat-soluble, whereas non-fluorescent compounds according to Ex 9-3 were water-soluble.

[1106]

[1107] Above, several embodiments of the present invention have been described, but those of ordinary skill in the art will be able to modify and change the present invention in various ways by adding, changing, deleting or adding components, etc., within the scope that does not depart from the spirit of the present invention described in the claims, and this will also be considered to be included within the scope of the rights of the present invention.

[1108]

Claims

1. A non-fluorescent compound represented by the following chemical formula 1, The non-fluorescent compound is capable of reducing fluorescence by at least one mechanism selected from static quenching and dynamic quenching, [Chemical Formula 1] Here, Ar is C5-C 50 Aryl, C2-C 50 Heteroaryl or C5-C 50 It is an aliphatic-aromatic mixed ring, wherein the above Ar is optionally substituted with at least one R", R1 to R6, R' and R" are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from, R x is a reactive group or a group having at least one such reactive group bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, The above reactive groups are carboxyl, carboxyl derivatives, carboxylate (-CO2 - ), carboxylates, hydroxyls, dienes, aldehydes, substituted ketones, sulfonyl halides, thiols, unsubstituted amino, primary amino, alkenes, alkynes, halogens, hydrazides, azides, imides, ketenes, isocyanates, thiocyanates, isothiocyanates, epoxides, maleimides, 1,2,4,5-tetrazine derivatives, cycloalkyne derivatives, cycloalkenes, triphosphates and phosphoramidites, substituted thioketones, haloformyl, formyl, acyl, acylamide, acyl azides, organic acid anhydrides, anilines, aziridines, boronates, carbodiimides, diazoalkynes, haloacetamides, imido esters, glycols, halotriazines, hydrazines, acyl halides, alkyl halides and aryl halides. is the functional group of choice, R s is a carrier molecule or a group in which at least one carrier molecule is bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, R7 and R8 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from, X is CR 20 R 21 , NR 22 , O, S, and R 20 Inland R 22 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x and R s are selected from, or combined with each other to form an optionally substituted 5- to 7-membered ring, n is an integer from 0 to 5, Two adjacent groups among R1 to R6 may combine with each other to form an optionally substituted 5- to 7-membered ring, The non-fluorescent compound represented by the above chemical formula 1 has at least one R X or R S exists, Non-fluorescent compound.

2. In paragraph 1, The above Ar is selected from [Ar-1] to [Ar-6] below, Here, The above [Ar-1] to [Ar-6] are optionally substituted with at least one R", * indicates the position of carbon that can be bonded to a five-membered ring containing nitrogen in chemical formula 1. Y is each independently CR 23 R 24 , NR 25 , O, S, The above R 23 Inland R 25 are each independently optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x and R s or are selected from, or are combined with each other to form an optionally substituted 5- to 7-membered ring, Non-fluorescent compound.

3. A non-fluorescent compound represented by the following chemical formula 6, The non-fluorescent compound is capable of reducing fluorescence by at least one mechanism selected from static quenching and dynamic quenching, [Chemical Formula 6] Here, R1 to R6, R' and R d are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from, R x is a reactive group or a group having at least one such reactive group bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, The above reactive groups are carboxyl, carboxyl derivatives, carboxylate (-CO2 - ), carboxylates, hydroxyls, dienes, aldehydes, substituted ketones, sulfonyl halides, thiols, unsubstituted amino, primary amino, alkenes, alkynes, halogens, hydrazides, azides, imides, ketenes, isocyanates, thiocyanates, isothiocyanates, epoxides, maleimides, 1,2,4,5-tetrazine derivatives, cycloalkyne derivatives, cycloalkenes, triphosphates and phosphoramidites, substituted thioketones, haloformyl, formyl, acyl, acylamide, acyl azides, organic acid anhydrides, anilines, aziridines, boronates, carbodiimides, diazoalkynes, haloacetamides, imido esters, glycols, halotriazines, hydrazines, acyl halides, alkyl halides and aryl halides. is the functional group of choice, R s is a carrier molecule or a group in which at least one carrier molecule is bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, R7 and R8 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from, n is an integer from 0 to 5, o is an integer from 0 to 6, Two adjacent groups among R1 to R6 may combine with each other to form an optionally substituted 5- to 7-membered ring, The non-fluorescent compound represented by the above chemical formula 6 has at least one R X or R S exists, Non-fluorescent compound.

4. A non-fluorescent compound represented by the following chemical formula 7, The non-fluorescent compound is capable of reducing fluorescence by at least one mechanism selected from static quenching and dynamic quenching, [Chemical Formula 7] Here, R1 to R6 and R' are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from, R x is a reactive group or a group having at least one such reactive group bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, The above reactive groups are carboxyl, carboxyl derivatives, carboxylate (-CO2 - ), carboxylates, hydroxyls, dienes, aldehydes, substituted ketones, sulfonyl halides, thiols, unsubstituted amino, primary amino, alkenes, alkynes, halogens, hydrazides, azides, imides, ketenes, isocyanates, thiocyanates, isothiocyanates, epoxides, maleimides, 1,2,4,5-tetrazine derivatives, cycloalkyne derivatives, cycloalkenes, triphosphates and phosphoramidites, substituted thioketones, haloformyl, formyl, acyl, acylamide, acyl azides, organic acid anhydrides, anilines, aziridines, boronates, carbodiimides, diazoalkynes, haloacetamides, imido esters, glycols, halotriazines, hydrazines, acyl halides, alkyl halides and aryl halides. is the functional group of choice, R s is a carrier molecule or a group in which at least one carrier molecule is bonded to a backbone comprising a hydrocarbon containing 1 to 40 carbon atoms, R7 is each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from, X is CR 20 R 21 , NR 22 , O, S, and R 20 Inland R 22 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C3-C 30 Cycloalkyl, optionally substituted C3-C 30 Heterocycloalkyl, optionally substituted aryl, optionally substituted heteroaryl, R x and R s are selected from, or combined with each other to form an optionally substituted 5- to 7-membered ring, n is an integer from 0 to 5, a and b of the above chemical formula 7 are R of the following chemical formula 8 31 Inland R 35 It is joined to two adjacent ones, [Chemical Formula 8] R 31 Inland R 35 Among the above, a and b of the chemical formula 7 are each independently hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, hydroxy, oxido(-O - ), optionally substituted C1-C 40 Alkoxy, optionally substituted C3-C 40 Cycloalkyloxy, optionally substituted C5-C 40 Aryloxy, optionally substituted C2-C 40 Heteroaryloxy, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, optionally substituted C1-C 40 Alkylthio, optionally substituted C5-C 40 Arylthio, optionally substituted C3-C 40 Cycloalkylthio, optionally substituted C2-C 40 Heteroarylthio, optionally substituted acylamino, acyloxy, substituted sulfonic acid ester, optionally substituted sulfonamide, substituted ester, nitroso(-N=O), halogen, optionally substituted silyl, optionally substituted amide, optionally substituted carbamate, nitrile, acetal, ketal, optionally substituted amino, thioamide, aminocarbonyloxy, aminosulfonyloxy, amidino group, sulfonyloxy, sulfonate, thiocarbonylamino isonitrile, cyanate, imide, ether, thioether, R x and R s is selected from, R 31 and R 35 In the above chemical formula 7, two adjacent groups that are not bonded to a and b may combine with each other to form an optionally substituted 5- to 7-membered ring, Q is hydrogen, optionally substituted C1-C 40 Alkyl, optionally substituted C1-C 40 Heteroalkyl, optionally substituted C2-C 40 alkenyl, optionally substituted C2-C 40 alkynyl, optionally substituted C3-C 20 Cycloalkyl, optionally substituted C3-C 20 Cycloalkenyl, optionally substituted C2-C 20 Heterocycloalkyl, optionally substituted C5-C 50 Aryl, optionally substituted C2-C 50 Heteroaryl, optionally substituted C5-C 50 Aralkyl, R x and R s is selected from, The non-fluorescent compound represented by the above chemical formula 7 has at least one R X or R S exists.

5. In any one of paragraphs 1 to 4, At least one R in the above non-fluorescent compound x or at least one R s If present, at least one R present in the non-fluorescent compound x or at least one R s is protected by a protector, Non-fluorescent compound.

6. In any one of paragraphs 1 to 4, The above non-fluorescent compound is characterized in that it is capable of reducing fluorescence in the wavelength range of 550 to 900 nm by dynamic quenching or reducing fluorescence in the wavelength range of 300 to 900 nm by static quenching. Non-fluorescent compound.

7. In any one of paragraphs 1 to 4, The above non-fluorescent compound is characterized in that it is capable of reducing fluorescence in the wavelength range of 550 to 900 nm through fluorescence resonance energy transfer or reducing fluorescence in the wavelength range of 300 to 900 nm through ground state quenching. Non-fluorescent compound.

8. In any one of paragraphs 1 to 4, The above non-fluorescent compound is characterized in that it is a compound for labeling nucleic acids. Non-fluorescent compound.

9. A conjugate comprising a non-fluorescent compound according to any one of claims 1 to 4 as a quencher.

10. In paragraph 9, The above conjugate is a nucleotide conjugate, Conjugate.

11. In paragraph 9, The above conjugate is a probe or primer, Conjugate.

12. A quencher comprising a non-fluorescent compound according to any one of claims 1 to 4; and phosphor; A conjugate containing .

13. A first quencher comprising a non-fluorescent compound according to any one of claims 1 to 4; A second quencher selected from azo, coumarin, cyanine, bodipy, floracene, rhodamine, pyrene, carbopyronine, benzo[c,d]indole, oxazine, xanthen, thioxanthen, acridine and derivatives thereof; and phosphor; including, Conjugate.

14. In paragraph 13, The second quencher is dabcyl, Eclipse TM , Black Hole Quencher TM BHQ0 (BHQnova), Black Hole Quencher TM BHQ1, Black Hole Quencher TM BHQ2, Black Hole Quencher TM BHQ3, BlackBerry TM Quencher 650 (BBQ650 TM ), Iowa Black TM FQ(IABkFQ), SFC TM Q1, SFC TM Q2, Iowa Black TM RQ-n1, Iowa Black TM RQ-n2 and Iowa Black TM RQSp, TAMRA, Deep Dark Quencher I (DDQ I), Deep Dark Quencher II (DDQ II), QXL TM 520, QXL TM 570, QXL TM 610, QXL TM 670, IRQXL TM , IRDye TM , QC-1, QSY TM , QSY TM 2, at least one selected from BMN-Q460, BMN-Q535, BMN-Q1, BMN-Q2, BMN-Q590, BMN-Q620, BMN-Q651, Conjugate.

15. In paragraph 12, The above fluorescent substance is at least one selected from coumarin, cyanine, bodipy, phlorsane, rhodamine, pyrene, carbopyronine, oxazine, xanthen, thioxanthen, acridine and / or derivatives thereof. conjugate 16. In paragraph 15, 상기 형광체는 6-FAM TM , TET TM , JOE TM , VIC®, HEX TM , NED TM , PET®, ROX TM , TAMRA TM , TET TM , Texas Red®, SUN, MAX, ABY, JUN, LIZ, TAZ, CAL Fluor® Gold 540, CAL Fluor® Orange 560, CAL Fluor® Red 590, CAL Fluor® Red 610, CAL Fluor® Red 635, Cy® (cyanine) 3, Cy® 3.5, Cy® 5, Cy® 5.5, Cy® 7, Cy® 7.5, Quasar® 570, Quasar® 670, Quasar® 705, Rhodamine Green TM , Rhodamine Red TM , LightCycler® Cyan 500, LightCycler® Red 610, LightCycler® Red 640, LightCycler® Red 670, LightCycler® Red 705, Oregon Green® 488, Oregon Green® 500, Oregon Green® 514, the Alexa Fluor® dyes 350, 405, 488, 532, 546, 555, 568, 594, 610, 647, 680 and Alexa Fluor® 750, the BODIPY® dyes, Epoch Blue, AMCA, Marina Blue®, Pacific Blue TM , Pacific Green TM , Pacific Orange TM , Yakima Yellow TM , the ATTO dyes 390, 425, 465, 488, 495, 514, 520, 532, Rho6G, 542, 550, 565, Rho3B, Rho11, Rho12, Thio12, Rho101, 590, 594, Rho13, 610, 620, Rho14, 633, 643, 647, 647N, 655, Oxa12, 665, 680, 700, 725, and ATTO 740, Texas red, Oyster 645, SFC TM -V, SFC TM -N, SFC TM 574, SFC TM 647, SFC TM -C610, SFC TM 620, SFC TM 670, SFC TM 705, Chamel TM 560, Chamel TM 610, Chamel TM 670 and Chamel TM At least one selected from 705, Conjugate.

17. In paragraph 12, Including an additional minor groove binder (MGB), Conjugate.

18. A composition for detecting nucleic acid comprising a conjugate according to Article 12.

19. A quencher comprising a non-fluorescent compound according to any one of claims 1 to 4; support; and A connecting member connecting the quencher and the support; including, Support for nucleic acid detection.

20. In paragraph 19, The support may be glass, cellulose, nylon, acrylamide gel, dextran, polystyrene or resin. Support for nucleic acid detection. 21.(a) a step of preparing a reaction mixture comprising a target nucleic acid, a reagent necessary for amplifying the target nucleic acid, and a conjugate according to claim 12; (b) a step of amplifying the target nucleic acid in the reaction mixture; and (c) a step of measuring the fluorescence intensity of the reaction mixture; including, Nucleic acid detection method.

22. In paragraph 21, The above step (b) is, (b-1) a step in which a nucleotide conjugate hybridized to the target nucleic acid is extended by a polymerase; (b-2) a step in which the quencher and the fluorophore of the nucleotide conjugate are separated from the target nucleic acid by the exonuclease activity of the polymerase; and (b-3) A step in which the fluorescent substance away from the quencher emits fluorescence; including, Nucleic acid detection method.

23. In paragraph 21, Further comprising a step (d) of measuring the amplification amount of the target nucleic acid from the fluorescence intensity measured in the above step (c). Nucleic acid detection method.

24. In paragraph 21, The target nucleic acid is selected from the group consisting of strand displacement amplification (SDA), polymerase chain reaction (PCR), reverse transcription polymerase chain reaction (RT-PCR), real-time polymerase chain reaction (RT-PCR), allele-specific polymerase chain reaction (ALL), ligase chain reaction (LCR), rolling circle amplification (RCA), isothermal multiple displacement amplification (IMDA), recombinase polymerase amplification (RPA), self-sustained sequence replication (3SR), single primer isothermal amplification (SPIA), multiple displacement amplification (MDA), whole genome amplification (WGA), and crossover. Cross-priming amplification (CPA), signal mediated amplification of RNA technology (SMART), transcription mediated amplification (TMA), nucleic acid sequence-based amplification (NASBA), and loop-mediated isothermal amplification (LAMP).Amplified by a method selected from Loop-mediated Isothermal Amplification), and Helicase Dependent Amplification (HDA). Nucleic acid detection method.

Citation Information

Patent Citations

  • Compound with 'active' and 'passive' dual targeting as well as pharmaceutical composition and application thereof

    CN113336743A

  • Bromo-heptamethine cyanine dye with near-infrared two-region absorption and fluorescence emission as well as preparation method and application of bromo-heptamethine cyanine dye

    CN115304539A

  • Symmetric, monofunctionalised polymethine dyes labelling reagents

    EP1221465A1

  • Compound inhibiting YAP-TEAD binding, and pharmaceutical composition for preventing or treating cancer, comprising compound as active ingredient

    EP3882242A1

  • NOVEL D-A-π-A-D TYPE OF HOLE TRANSPORTING MATERIALS AND METHOD OF PREPARATION THEREOF

    IN202241025324A